SYNAPTICS Inc - Quarter Report: 2022 March (Form 10-Q)

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 26, 2022


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission file number 000-49602

SYNAPTICS INCORPORATED

(Exact name of registrant as specified in its charter)

Delaware

77-0118518

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1109 McKay Drive

San Jose, California 95131

(Address of principal executive offices) (Zip code)

(408) 904-1100

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, par value $.001 per share	SYNA	The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Number of shares of Common Stock outstanding at April 28, 2022: 39,607,181

SYNAPTICS INCORPORATED

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED March 26, 2022

TABLE OF CONTENTS


			Page
Part I. Financial Information

	Item 1.	Condensed Consolidated Financial Statements (Unaudited):	3

		Condensed Consolidated Balance Sheets—March 26, 2022 and June 26, 2021	3

		Condensed Consolidated Statements of Income—Three and nine months ended March 26, 2022 and March 27, 2021	4

		Condensed Consolidated Statements of Stockholders’ Equity—Three and nine months ended March 26, 2022 and March 27, 2021	5

		Condensed Consolidated Statements of Cash Flows—Nine months ended March 26, 2022 and March 27, 2021	7

		Notes to Condensed Consolidated Financial Statements	8

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	37

	Item 4.	Controls and Procedures	37

Part II. Other Information

	Item 1.	Legal Proceedings	38

	Item 1A.	Risk Factors	38

	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38

	Item 6.	Exhibits	39

Signatures			40

PART I—FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except par value and share amounts)

(unaudited)


	March			June
	2022			2021
ASSETS
Current Assets:
Cash and cash equivalents	$	690.3		$	836.3
Short-term investments		64.6			-
Accounts receivable, net of allowances of $6.0 and $5.8 at March 2022 and June 2021, respectively		298.3			228.3
Inventories		145.9			82.0
Prepaid expenses and other current assets		48.1			33.1
Total current assets		1,247.2			1,179.7
Property and equipment at cost, net of accumulated depreciation of $125.9 and $131.0 at March 2022 and June 2021, respectively		63.1			91.2
Goodwill		814.5			570.0
Acquired intangibles, net		409.5			301.5
Non-current other assets		163.7			84.4
	$	2,698.0		$	2,226.8
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	135.6		$	97.6
Accrued compensation		80.1			76.4
Income taxes payable		38.0			29.4
Other accrued liabilities		139.3			96.2
Convertible notes, net		-			487.1
Total current liabilities		393.0			786.7
Long-term debt		982.6			394.4
Other long-term liabilities		164.7			78.5
Total liabilities		1,540.3			1,259.6
Stockholders' Equity:
Common stock:
$0.001 par value; 120,000,000 shares authorized, 67,722,867 and 66,963,006 shares issued, and 39,598,246 and 35,331,903 shares outstanding, at March 2022 and June 2021, respectively		0.1			0.1
Additional paid-in capital		897.8			1,391.5
Treasury stock: 28,124,621 and 31,631,103 common treasury shares at March 2022 and June 2021, respectively, at cost		(694.5	)		(1,205.4	)
Accumulated other comprehensive income		(1.3	)		-
Retained earnings		955.6			781.0
Total stockholders' equity		1,157.7			967.2
	$	2,698.0		$	2,226.8

See accompanying notes to condensed consolidated financial statements (unaudited).

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in millions, except per share data)

(unaudited)


	Three Months Ended						Nine Months Ended
	March						March
	2022			2021			2022			2021
Net revenue	$	470.1		$	325.8		$	1,263.3		$	1,011.8
Cost of revenue		216.3			170.3			586.3			571.4
Gross margin		253.8			155.5			677.0			440.4
Operating expenses:
Research and development		98.2			77.5			273.2			235.7
Selling, general, and administrative		44.2			36.8			130.1			111.6
Acquired intangibles amortization		12.0			8.7			29.6			24.1
Restructuring costs		11.3			0.9			17.8			7.1
Gain on sale of audio technology assets		-			-			-			(34.2	)
Total operating expenses		165.7			123.9			450.7			344.3
Operating income		88.1			31.6			226.3			96.1
Interest and other expense, net		(6.7	)		(7.0	)		(18.3	)		(17.7	)
Gain on sale and leaseback transaction		5.4			-			5.4			-
Loss on redemption of convertible notes		-			-			(8.1	)		-
Income before provision for income taxes and equity investment loss		86.8			24.6			205.3			78.4
Provision for income taxes		24.4			10.4			32.3			16.4
Equity investment gain (loss)		2.5			(0.4	)		1.6			(1.4	)
Net income	$	64.9		$	13.8		$	174.6		$	60.6
Net income per share:
Basic	$	1.64		$	0.39		$	4.50		$	1.75
Diluted	$	1.59		$	0.35		$	4.29		$	1.62
Shares used in computing net income per share:
Basic		39.5			35.0			38.8			34.7
Diluted		40.7			39.1			40.7			37.5

See accompanying notes to condensed consolidated financial statements (unaudited).

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in millions, except share amounts)

(unaudited)


	Three and Nine months ended March 26, 2022
	Common Stock
	Shares		Amount		Additional Paid-In Capital			Treasury Stock			Accumulated Other Comprehensive Income			Retained Earnings		Total Stockholders' Equity
Balance at June 2021		66,963,006	$	0.1	$	1,391.5		$	(1,205.4	)	$	-		$	781.0	$	967.2
Net income		-		-		-			-			-			40.2		40.2
Issuance of common stock for share-based award compensation plans		384,866		-		7.8			-			-			-		7.8
Payroll taxes for deferred stock units		-		-		(27.7	)		-			-			-		(27.7	)
Redemption of convertible debt						(518.2	)		510.9			-					(7.3	)
Share-based compensation		-		-		21.2			-			-			-		21.2
Balance at September 2021		67,347,872		0.1		874.6			(694.5	)		-			821.2		1,001.4
Net income		-		-		-			-			-			69.5		69.5
Other comprehensive loss		-		-		-			-			(0.1	)		-		(0.1	)
Total comprehensive income		-		-		-			-			-			-		69.4
Issuance of common stock for share-based award compensation plans		295,796		-		0.8			-			-			-		0.8
Payroll taxes for deferred stock units		-		-		(35.8	)		-			-			-		(35.8	)
Share-based compensation attributable to acquisition		-		-		1.7			-			-			-		1.7
Share-based compensation		-		-		26.4			-			-			-		26.4
Balance at December 2021		67,643,668		0.1		867.7			(694.5	)		(0.1	)		890.7		1,063.9
Net income		-		-		-			-						64.9		64.9
Other comprehensive loss		-		-		-			-			(1.2	)		-		(1.2	)
Total comprehensive income		-		-		-			-			-			-		63.7
Issuance of common stock for share-based award compensation plans		79,199		-		6.5			-			-			-		6.5
Payroll taxes for deferred stock units		-		-		(2.6	)		-			-			-		(2.6	)
Share-based compensation		-		-		26.2			-			-			-		26.2
Balance at March 2022		67,722,867	$	0.1	$	897.8		$	(694.5	)	$	(1.3	)	$	955.6	$	1,157.7

See accompanying notes to condensed consolidated financial statements (unaudited).

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in millions, except share amounts)

(unaudited)


	Three and Nine months ended March 27, 2021
	Common Stock
	Shares		Amount		Additional Paid-In Capital			Treasury Stock			Retained Earnings			Total Stockholders' Equity
Balance at June 2020		65,871,648	$	0.1	$	1,340.2		$	(1,222.6	)	$	701.4		$	819.1
Net loss		-		-		-			-			(2.8	)		(2.8	)
Issuance of common stock for share-based award compensation plans		296,917		-		10.4			-			-			10.4
Payroll taxes for deferred stock units		-		-		(5.6	)		-			-			(5.6	)
Share-based compensation attributable to acquisition		-		-		3.2			-			-			3.2
Share-based compensation		-		-		14.4			-			-			14.4
Balance at September 2020		66,168,565		0.1		1,362.6			(1,222.6	)		698.6			838.7
Net income		-		-		-			-			49.6			49.6
Issuance of common stock for share-based award compensation plans		508,776		-		0.8			-			-			0.8
Payroll taxes for deferred stock units		-		-		(20.2	)		-			-			(20.2	)
Share-based compensation		-		-		19.1			-			-			19.1
Balance at December 2020		66,677,341		0.1		1,362.3			(1,222.6	)		748.2			888.0
Net income		-		-		-			-			13.8			13.8
Issuance of common stock for share-based award compensation plans		252,121		-		15.7			-			-			15.7
Payroll taxes for deferred stock units		-		-		(1.2	)		-			-			(1.2	)
Share-based compensation		-		-		16.3			-			-			16.3
Balance at March 2021		66,929,462	$	0.1	$	1,393.1		$	(1,222.6	)	$	762.0		$	932.6

See accompanying notes to condensed consolidated financial statements (unaudited).

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)


	Nine Months Ended
	March
	2022			2021
Cash flows from operating activities
Net income	$	174.6		$	60.6
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based compensation costs		73.8			49.8
Depreciation and amortization		17.9			15.5
Acquired intangibles amortization		91.5			84.5
Gain on sale of audio technology assets		-			(34.2	)
Gain on sale and leaseback transaction		(5.4	)		-
Loss on redemption of convertible notes		8.1			-
Deferred taxes		(27.7	)		(10.1	)
Amortization of convertible debt discount and issuance costs		1.6			14.3
Amortization of debt issuance costs		1.2			0.3
Amortization of cost of development services		7.5			6.7
Equity investment (gain) loss		(1.6	)		1.4
Foreign currency remeasurement gain		(0.8	)		(1.9	)
Other		(1.6	)		-
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net		(57.3	)		(31.3	)
Inventories		(41.3	)		65.8
Prepaid expenses and other current assets		4.4			(7.9	)
Other assets		18.3			(4.3	)
Accounts payable		21.1			37.9
Accrued compensation		(7.0	)		(1.7	)
Income taxes payable		14.7			(11.8	)
Other accrued liabilities		16.4			(19.3	)
Net cash provided by operating activities		308.4			214.3
Cash flows from investing activities
Acquisition of businesses, net of cash and cash equivalents acquired		(504.8	)		(626.5	)
Proceeds from sale of audio technology assets		-			34.2
Proceeds from sale of property and equipment		55.9			-
Proceeds from maturities of investments		12.2			95.8
Purchase of short-term securities		(5.8	)		-
Purchases of property and equipment		(26.9	)		(15.5	)
Cost method investment		-			(5.0	)
Net cash used in investing activities		(469.4	)		(517.0	)
Cash flows from financing activities
Proceeds from issuance of debt		600.0			400.0
Payment on line of credit borrowings and debt		(1.5	)		(100.0	)
Payment of debt issuance costs		(11.2	)		(5.9	)
Proceeds from issuance of shares		15.1			26.9
Payroll taxes for deferred stock and market stock units		(66.1	)		(27.0	)
Payment for redemption of convertible notes		(505.6	)		-
Refundable deposit paid to vendor		(16.6	)		-
Return of deposit received from vendor		2.8			-
Net cash provided by financing activities		16.9			294.0
Effect of exchange rate changes on cash and cash equivalents		(1.9	)		1.5
Net decrease in cash and cash equivalents		(146.0	)		(7.2	)
Cash and cash equivalents at beginning of period		836.3			763.4
Cash and cash equivalents at end of period	$	690.3		$	756.2
Supplemental disclosures of cash flow information
Cash paid for taxes	$	41.4		$	37.9
Cash refund on taxes	$	3.7		$	0.3
Non-cash investing and financing activities:
Purchases of property and equipment in current liabilities	$	3.1		$	4.4

See accompanying notes to condensed consolidated financial statements (unaudited)

SYNAPTICS INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, and United States generally accepted accounting principles, or U.S. GAAP. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to SEC rules and regulations. In our opinion, the financial statements include all adjustments, which are of a normal and recurring nature and necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended June 26, 2021.

The condensed consolidated financial statements include our financial statements and those of our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

Our fiscal year is the 52- or 53-week period ending on the last Saturday in June. Our fiscal 2022 and 2021 are 52-week periods ending June 25, 2022 and June 26, 2021, respectively. The fiscal periods presented in this report are 13-week and 39-week periods ended March 26, 2022, and March 27, 2021, respectively.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments and loss contingencies. We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, including our expectations regarding the potential impacts on our business of the pandemic related to the novel coronavirus, or COVID-19, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Cash Equivalents

Cash equivalents consist of highly liquid investments with original maturities of three months or less. As of March 26, 2022 and June 26, 2021, our cash equivalents included bank deposits with a carrying value of $158.6 million and $509.1 million, respectively, which approximates fair value, and are included in cash and cash equivalents on the condensed consolidated balance sheets.

Short-Term Investments

Our short-term investments have been classified and accounted for as available-for-sale securities. We determine the appropriate classification of our investments at the time of purchase and reevaluate the classification at each balance sheet date. Our available-for-sale securities are carried at fair value, with unrealized gains and losses, net of taxes, reported within accumulated other comprehensive income (loss), or AOCI, in stockholders’ equity. As of March 26, 2022, the total unrealized loss reported within AOCI was $1.3 million. At June 26, 2021, there were no unrealized gains or losses.

Foreign Currency Transactions and Foreign Exchange Contracts

The U.S. dollar is our functional and reporting currency. We remeasure our monetary assets and liabilities not denominated in the functional currency into U.S. dollar equivalents at the rate of exchange in effect on the balance sheet date. We measure and record non-monetary balance sheet accounts at the historical rate in effect at the date of transaction. We remeasure foreign currency expenses at the weighted average exchange rate in the month that the transaction occurred. Our foreign currency transactions and remeasurement gains and losses are included in selling, general, and administrative expenses in the condensed consolidated statements of income and resulted in immaterial amounts in each of the three and nine months ended March 26, 2022, and the three and nine months ended March 27, 2021.

Leases

We determine if a contract is a lease or contains a lease at the inception of the contract and reassess that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease right-of-use, or ROU, assets are included in non-current other assets on our condensed consolidated balance sheet. Operating lease liabilities are separated into a current portion, included within accrued liabilities on our condensed consolidated balance sheet, and a non-current portion, included within other long-term liabilities on our condensed consolidated balance sheet. We do not have any finance lease ROU assets or liabilities. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We do not obtain and control the right to use the identified asset until the lease commencement date.

Our lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. Because the interest rate implicit in the lease is not readily determinable, we generally use our incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. We factor in publicly available data for instruments with similar characteristics when calculating our incremental borrowing rates. Our ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability.

The term of our leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also include options to renew or extend the lease (including by not terminating the lease) that we are reasonably certain to exercise. We establish the term of each lease at lease commencement and reassess that term in subsequent periods when one of the triggering events outlined in Accounting Standards Codification Topic 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term.

Our lease contracts often include lease and non-lease components. For our leases, we have elected the practical expedient offered by the standard to not separate lease from non-lease components and account for them as a single lease component.

We have elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.

2. Revenue Recognition

We account for revenue using Accounting Standards Codification Topic 606, or ASC 606, Revenue from Contracts with Customers. Our revenue is primarily generated from the sale of application specific integrated circuit chips, or ASIC chips, either directly to a customer or to a distributor. Revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to receive in exchange for those goods or services. All of our revenue, except an inconsequential amount, is recognized at a point in time, either on shipment or delivery of the product, depending on customer terms and conditions. We generally warrant our products for a period of 12 months from the date of sale and estimate probable product warranty costs at the time we recognize revenue as the warranty is considered an assurance warranty and not a performance obligation. Non-product revenue is recognized over the same period of time such performance obligations are satisfied. We then select an appropriate method for measuring satisfaction of the performance obligations.

Revenue from sales to distributors is recognized upon shipment of the product to the distributors (sell-in basis). Master sales agreements are in place with certain customers, and these agreements typically contain terms and conditions with respect to payment, delivery, warranty and supply. In the absence of a master sales agreement, we consider a customer's purchase order or our standard terms and conditions to be the contract with the customer.

Our pricing terms are negotiated independently, on a stand-alone basis. In determining the transaction price, we evaluate whether the price is subject to refund or adjustment to determine the net consideration which we expect to receive for the sale of such products. In limited situations, we make sales to certain customers under arrangements where we grant stock rotation rights, price protection and price allowances; variable consideration associated with these rights is expected to be inconsequential. These adjustments and incentives are accounted for as variable consideration, classified as other current liabilities under the revenue standard, and are shown as customer obligations in Note 9 Other Accrued Liabilities and Other Long-Term Liabilities. We estimate the amount of variable consideration for such arrangements based on the expected value to be provided to customers, and we do not believe that there will be significant changes to our estimates of variable consideration. When incentives, stock rotation rights, price protection, volume discounts, or price allowances are applicable, they are estimated and recorded in the period the related revenue is recognized. Stock rotation reserves are based on historical return rates applied to distributor inventory subject to stock rotation rights and recorded as a reduction to revenue with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is

expected to be returned and recorded as prepaid expenses and other current assets. In limited circumstances, we enter into volume-based tiered pricing arrangements and we estimate total unit volumes under such arrangements to determine the expected transaction price for the units expected to be transferred. Such arrangements are accounted for as contract liabilities within other accrued liabilities. Sales returns liabilities are recorded as refund liabilities within other accrued liabilities.

Our accounts receivable balance is from contracts with customers and represents our unconditional right to receive consideration from customers. Payments are generally due within three months of completion of the performance obligation and subsequent invoicing and therefore, do not include significant financing components. To date, there have been no material bad debt charges recorded on accounts receivable. There were $1.0 million in contract assets recorded on the condensed consolidated balance sheets as of March 26, 2022 and $1.9 million as of June 26, 2021. Contract assets are presented as part of prepaid expenses and other current assets.

Contract liabilities and refund liabilities were $29.4 million and $53.2 million, respectively, as of March 26, 2022 and $7.0 million and $36.1 million, respectively, as of June 26, 2021. Both contract liabilities and refund liabilities are presented as customer obligations in Note 9 Balance Sheet Components. During the three and nine months ended March 26, 2022, we recognized $0.2 million and $3.5 million, respectively, in revenue related to contract liabilities, which was outstanding as of the beginning of each such fiscal year. During the three and nine months ended March 27, 2021, we recognized $0.3 million and $1.4 million, respectively, in revenue related to contract liabilities, which was outstanding as of the beginning of each such fiscal year.

We invoice customers for each delivery upon shipment and recognize revenue in accordance with delivery terms. As of March 26, 2022, we did not have any remaining unsatisfied performance obligations with an original duration greater than one year. Accordingly, under the optional exception provided by ASC 606, we do not disclose revenues allocated to future performance obligations of partially completed contracts. We account for shipping and handling costs as fulfillment costs before the customer obtains control of the goods and include these costs in cost of revenue. We account for collection of all taxes on a net basis.

We incur commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded as a selling, general and administrative expense in the condensed consolidated statements of income) are expensed when the product is shipped because such commissions are owed after shipment.

Revenue from contracts with customers disaggregated by geographic area based on customer location and product category is presented in Note 14 Segment, Customers, and Geographical Information.

3. Net Income Per Share

The computation of basic and diluted net income per share was as follows (in millions, except per share data):


	Three Months Ended				Nine Months Ended
	March				March
	2022		2021		2022		2021
Numerator:
Net income	$	64.9	$	13.8	$	174.6	$	60.6
Denominator:
Shares, basic		39.5		35.0		38.8		34.7
Effect of dilutive share-based awards and convertible notes		1.2		4.1		1.9		2.8
Shares, diluted		40.7		39.1		40.7		37.5
Net income per share:
Basic	$	1.64	$	0.39	$	4.50	$	1.75
Diluted	$	1.59	$	0.35	$	4.29	$	1.62

Our basic net income per share amounts for each period presented have been computed using the weighted average number of shares of common stock, $0.001 par value, or the common stock, outstanding over the period measured. Our diluted net income per share amounts for each period presented include the weighted average effect of potentially dilutive shares. We use the "treasury stock" method to determine the dilutive effect of our stock options, restricted stock units, or RSUs, market stock units, or MSUs, performance stock units, or PSUs, and our convertible notes, which were settled in August 2021.

Dilutive net income per share amounts do not include the potential weighted average effect of 68,521 and 32,109 shares of common stock related to certain share-based awards that were outstanding during the three months ended March 26, 2022 and March 27, 2021, respectively, and 31,430 and 68,795 shares of common stock related to certain share-based awards that were outstanding during the nine months ended March 26, 2022, and March 27, 2021, respectively. These share-based awards were not included in the computation of diluted net income per share because their effect would have been antidilutive.

4. Fair Value

Our carrying values of cash equivalents approximate their fair values due to the short period of time to maturity.

The fair values of our accounts receivable and accounts payable approximate their carrying values because of the short-term nature of those instruments. Intangible assets, property and equipment, and goodwill are measured at fair value on a non-recurring basis if impairment is indicated. The interest rate on our bank debt is variable, which is subject to change from time to time to reflect a market interest rate; we currently do not have any bank borrowings, however, when we do have outstanding borrowing the carrying value of our bank debt approximates fair value.

Our investments, which we hold as available-for-sale, consist primarily of certificates of deposit and corporate and municipal bonds are measured at fair value based on quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, or valuations based on models where the significant inputs are observable, such as interest rates or yield curves, or can be corroborated by observable market data. At March 26, 2022, approximately $25.4 million of our investments are expected to mature within one year, and approximately $39.2 million is expected to mature beyond one year. Our total investments are presented as short-term investments in the condensed consolidated balance sheet.

The fair value of our $400.0 million principal amount of 4.0% senior notes due 2029 is measured at fair value for disclosure purposes. The fair value of the senior notes as of March 26, 2022 and June 26, 2021 was approximately $375.5 million and $401.5 million, respectively, based on the last trading price of the senior notes for the respective periods.

At March 26, 2022, our $600.0 million term loan due in December 2028 is a variable rate instrument and the carrying value of the term loan approximates its fair value.

5. Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value and consisted of the following (in millions):


	March		June
	2022		2021
Raw materials and work-in-progress	$	76.9	$	49.1
Finished goods		69.0		32.9
	$	145.9	$	82.0

We record a write-down, if necessary, to reduce the carrying value of inventory to its net realizable value. The effect of these write-downs is to establish a new cost basis in the related inventory, which we do not subsequently write up. We also record a liability and charge to cost of revenue for estimated losses on inventory we are obligated to purchase from our contract manufacturers when such losses become probable from customer delays, order cancellations, or other factors. The following factors influence our estimates: changes to or cancellations of customer orders, unexpected or sudden decline in demand, rapid product improvements, technological advances, and termination or changes by our original equipment manufacturers, or OEM, customers of any product offerings incorporating our product solutions.

6. Acquisition

DSP Group, Inc.

On August 30, 2021, we entered into an agreement and plan of merger with DSP Group, Inc., or DSPG, to acquire all of the equity of DSPG, a leading global provider of voice and wireless chipset solutions for converged communications, for $22.00 per share in an all-cash transaction, referred to as the DSPG acquisition. The DSPG acquisition closed on December 2, 2021, or the DSPG Closing Date, whereupon we obtained voice and wireless technology and product solutions for converged communications.

The DSPG acquisition has been accounted for using the purchase method of accounting in accordance with the business acquisition guidance. Under the purchase accounting method, the total estimated purchase consideration of the acquisition was allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their relative fair values. The

excess of the purchase consideration over the net tangible and identifiable intangible assets acquired and liabilities has been recorded as goodwill. Our estimate of the fair values of the acquired intangible assets at March 26, 2022, is preliminary and subject to change and has been based on established and accepted valuation techniques performed with the assistance of our third-party valuation specialists. The primary areas of the preliminary purchase price allocation that are not yet finalized relate to the fair value of certain tangible assets acquired and liabilities assumed, the valuation of intangible assets acquired and related deferred income taxes. We expect to continue to obtain information for the purpose of determining the fair value of the net assets acquired at the acquisition date throughout the remainder of the measurement period.

The adjusted purchase price paid to acquire DSPG was $543.3 million.

The following table summarizes the preliminary amounts recorded for the estimated fair values of the assets acquired and liabilities assumed as of the DSPG Closing Date (in millions):


Cash and cash equivalents	$	40.5
Short-term investments		71.9
Accounts receivable, net		12.9
Inventory		22.6
Prepaid expenses and other current assets		4.0
Property and equipment		5.9
Intangible assets		199.5
Right-of-use lease asset		11.2
Severance pay fund		16.2
Deferred tax asset		6.4
Non-current other assets		2.3
Total identifiable assets acquired		393.4
Accounts payable		(6.7	)
Other accrued expenses		(19.0	)
Short-term lease liabilities		(1.7	)
Long-term lease liabilities		(9.4	)
Accrued severance		(16.4	)
Deferred tax liability		(38.1	)
Other long-term liabilities		(3.3	)
Total liabilities		(94.6	)
Net identifiable assets acquired		298.8
Goodwill		244.5
Net assets acquired	$	543.3

During the three months ended March 26, 2022, the Company recorded measurement period adjustments of $12.1 million to goodwill consisting of increases in non-current deferred tax assets of $6.1 million, $0.6 million in other accrued liabilities and $7.6 million relating to the acceleration of certain equity awards, offset by a decrease of $1.0 million in acquired in-process research and development.

The following table summarizes the preliminary estimated fair value of the intangible assets as of the DSPG Closing Date (in millions):


	Estimated Weighted Average Useful Lives in Years		Estimated Fair Value

Developed technology		5.0	$	107.5
Customer contracts and related relationships		4.0		65.0
In process research and development	N/A			15.0
Backlog		1.0		11.0
Trade name		1.0		1.0
Estimated fair value of acquired intangibles			$	199.5

We estimated the fair value of the identified intangible assets using a discounted cash flow model for each of the underlying identified intangible assets. These fair value measurements were based on significant inputs not observable in the market and thus represent a Level 3 measurement. Key assumptions include the level and timing of expected future cash flows, conditions and demands specific to each intangible asset over its remaining useful life, and discount rates we believe to be consistent with the inherent risks associated with each type of asset, which range from 4% to 18%. The fair value of these intangible assets is primarily affected by the projected revenue, gross margins, operating expenses, the technology migration curve, customer ramp up period and the anticipated timing of the projected income associated with each intangible asset coupled with the discount rates used to derive their estimated present values. We believe the level and timing of expected future cash flows appropriately reflects market participant assumptions.

In-process research and development consists of advanced semiconductor telecommunications products for the Internet of Things, or IoT, market. We expect to complete the in-process research and development project in calendar year 2023.

The value of goodwill reflects the anticipated synergies of the combined operations and workforce of DSPG as of the DSPG Closing Date. As of March 26, 2022, none of the goodwill is expected to be deductible for income tax purposes.

Prior to the DSPG acquisition, we did not have an existing relationship or transactions with DSPG.

The condensed consolidated financial statements include approximately $44.6 million of revenue from DSPG Closing Date through March 26, 2022. It is impracticable to determine the effect on net income attributable to DSPG as we initiated the integration of a substantial portion of DSPG into our ongoing operations during the second quarter of fiscal 2022, which was completed in the subsequent quarter.

7. Acquired Intangibles and Goodwill

Acquired Intangibles

The following table summarizes the life, the gross carrying value and the related accumulated amortization of our acquired intangible assets (in millions):


			March 2022							June 2021
	Weighted Average Life in Years		Gross Carrying Value		Accumulated Amortization			Net Carrying Value		Gross Carrying Value		Accumulated Amortization			Net Carrying Value
Audio and video technology		5.4	$	189.6	$	(96.7	)	$	92.9	$	138.6	$	(97.6	)	$	41.0
Customer relationships		4.1	$	190.5	$	(91.4	)		99.1		125.5		(63.8	)		61.7
Wireless connectivity technology		6.0	$	128.0	$	(27.9	)		100.1		93.0		(14.2	)		78.8
Video interface technology		3.0	$	82.0	$	(45.5	)		36.5		82.0		(25.1	)		56.9
Display driver technology		7.0	$	20.4	$	(19.6	)		0.8		20.4		(17.5	)		2.9
Backlog		1.0	$	11.0	$	(3.7	)		7.3		12.0		(12.0	)		-
Licensed technology and other		4.5	$	9.9	$	(6.9	)		3.0		13.0		(8.1	)		4.9
Patents		8.0	$	4.4	$	(3.6	)		0.8		4.4		(3.2	)		1.2
Tradename		4.4	$	5.8	$	(2.8	)		3.0		4.8		(1.7	)		3.1
In process research and development	Not applicable		$	66.0		-			66.0		51.0		-			51.0
Acquired intangibles totals		4.8	$	707.6	$	(298.1	)	$	409.5	$	544.7	$	(243.2	)	$	301.5

The total amortization expense for the acquired intangible assets was $37.1 million and $27.5 million for the three months ended March 26, 2022, and March 27, 2021, respectively, and $91.5 million and $84.5 million for the nine months ended March 26, 2022 and March 27, 2021, respectively. During the three months ended March 26, 2022, and March 27, 2021, $25.1 million and $18.8 million, respectively, and $61.9 million and $60.4 million for the nine months ended March 26, 2022 and March 27, 2021, respectively, of amortization expense was included in our condensed consolidated statements of income in cost of revenue; the remainder was included under operating expenses in acquired intangibles amortization.

Goodwill

Goodwill represents the excess of the purchase price over the fair value of net tangible and identifiable intangible assets acquired. The changes in our goodwill balance for the nine months ended March 26, 2022 reflect our preliminary estimate of goodwill associated with the DSPG acquisition.

8. Leases

Our leases mainly include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options that are under our discretion. The leases expire at various dates through fiscal year 2029, some of which include options to extend the lease for up to 5 years. For the nine months ended March 26, 2022 and March 27, 2021, we recorded approximately $9.1 million and $7.5 million, respectively, of operating leases expense. Our short-term leases are immaterial.

As of March 26, 2022, and June 26, 2021, the components of leases are as follows (in millions):


	March		June
	2022		2021
Operating lease right-of-use assets	$	63.3	$	31.7
Operating lease liabilities	$	8.8	$	9.3
Operating lease liabilities, long-term		54.6		24.0
Total operating lease liabilities	$	63.4	$	33.3

Supplemental cash flow information related to leases, including from acquisitions, is as follows (in millions):


	Nine Months Ended
	March
	2022		2021
Cash paid for operating leases included in operating cash flows	$	9.1	$	7.3
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets		39.4		21.7

As of March 26, 2022, the weighted average remaining lease term is 8.1 years, and the weighted average discount rate is 4.1%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):


	Operating
	Lease
Fiscal Year	Payments
Remainder of 2022	$	1.5
2023		10.0
2024		9.3
2025		9.4
2026		9.1
Thereafter		37.2
Total future minimum operating lease payments		76.5
Less: interest		(13.1	)
Total lease liabilities	$	63.4

Sale and Leaseback Transaction

On February 8, 2022, we executed a sale and leaseback transaction of our properties located at 1109-1251 McKay Drive and 1140-1150 Ringwood Court, San Jose, California, for a purchase price, net of closing and other expenses payable by us, of $55.9 million. Concurrent with the sale, we entered into a lease agreement with the Buyer to lease back the land and properties located at 1109 and 1151 McKay Drive, San Jose, California, for an initial term of 12 years and a renewal option for an additional seven years. The transaction qualified for sale and leaseback and operating lease accounting classification, and we recorded a gain of $5.4 million which is recorded in the gain on sale and leaseback transaction line in the condensed consolidated statement of income in the third quarter of 2022.

9. Balance Sheet Components

Other non-current assets consisted of the following (in millions):


	March		June
	2022		2021
Deferred income taxes	$	51.6	$	28.3
Right-of-use assets		63.3		31.7
Security deposits		28.2		3.8
Other		20.6		20.6
	$	163.7	$	84.4

Other accrued liabilities consisted of the following (in millions):


	March		June
	2022		2021
Customer obligations	$	82.6	$	43.1
Inventory obligations		13.9		17.0
Operating lease liabilities, short-term		8.8		9.3
Other		34.0		26.8
	$	139.3	$	96.2

Other long-term liabilities consisted of the following (in millions):


	March		June
	2022		2021
Operating lease liabilities, long-term	$	54.6	$	24.0
Deferred tax liability		56.1		27.1
Income taxes payable, long-term		33.6		15.4
Other		20.4		12.0
	$	164.7	$	78.5

10. Indemnifications and Contingencies

Indemnifications

In connection with certain agreements, we are obligated to indemnify the counterparty against third party claims alleging infringement of certain intellectual property rights by us. We have also entered into indemnification agreements with our officers and directors. Maximum potential future payments under these agreements cannot be estimated because these agreements generally do not have a maximum stated liability. However, historical costs related to these indemnification provisions have not been significant. We have not recorded any liability in our condensed consolidated financial statements for such indemnification obligations.

Contingencies

We have in the past, and may in the future, receive notices from third parties that claim our products infringe their intellectual property rights. We cannot be certain that our technologies and products do not and will not infringe issued patents or other proprietary rights of third parties.

Any infringement claims, with or without merit, could result in significant litigation costs and diversion of management and financial resources, including the payment of damages, which could have a material adverse effect on our business, financial condition, and results of operations.

11. Debt

Senior Debt

On March 11, 2021, we completed an offering of $400.0 million aggregate principal amount of 4.0% senior notes due 2029, or the Senior Notes, in a private offering. The Senior Notes were issued pursuant to an indenture, dated as of March 11, 2021, or the Indenture, by and among our company, the guarantors named therein and Wells Fargo Bank, National Association, as trustee.

The Indenture provides that the Senior Notes will bear interest at a rate of 4.0% per annum, payable in cash semi-annually in arrears on December 15 and June 15 of each year, commencing on June 15, 2021. The Senior Notes will mature on June 15, 2029 and are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by each of our current and future domestic restricted subsidiaries that guarantee our obligations under our senior secured credit facilities.

Prior to June 15, 2024, we may redeem the Senior Notes, in whole or in part, at a redemption price of 100% of the principal amount thereof, plus a make-whole premium set forth in the Indenture, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date.

On or after June 15, 2024, we may redeem some or all of the Senior Notes at the redemption prices specified below, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date:


Year	Price
2024		102	%
2025		101	%
2026 and thereafter		100	%

In addition, at any time prior to June 15, 2024, we may redeem up to 40% of the aggregate principal amount of the Senior Notes at a redemption price equal to 104% of the principal amount thereof, plus accrued and unpaid interest, if any, up to, but excluding, the applicable redemption date with the net cash proceeds from one or more equity offerings by us.

The Senior Notes are the general unsecured obligations of our company. The Senior Note guarantees are the senior unsecured obligations of each guarantor. Under certain circumstances, the guarantors may be released from their Senior Note guarantees without consent of the holders of Senior Notes. Under the terms of the Indenture, the Senior Notes rank equally in right of payment with all of our and the guarantors’ existing and future senior indebtedness, and rank contractually senior in right of payment to our and the guarantors’ future indebtedness and other obligations that are, by their terms, expressly subordinated in right of payment to the Senior Notes. The Senior Notes are effectively subordinated to our and the guarantors’ existing and future secured indebtedness, including secured indebtedness under our senior secured credit facilities, to the extent of the value of the assets securing such indebtedness. The Senior Notes and guarantees are structurally subordinated to all existing and future indebtedness and liabilities (including trade payables) of our subsidiaries that do not guarantee the Senior Notes.

The Indenture contains covenants that, subject to exceptions and qualifications, among other things, limit our ability and the ability of our Restricted Subsidiaries (as defined in the Indenture) to (i) incur additional indebtedness and guarantee indebtedness; (ii) pay dividends or make other distributions or repurchase or redeem our company’s or any parent’s capital stock; (iii) prepay, redeem or repurchase certain indebtedness; (iv) issue certain preferred stock or similar equity securities; (v) make loans and investments; (vi) dispose of assets; (vii) incur liens; (viii) enter into transactions with affiliates; (ix) enter into agreements restricting its subsidiaries’ ability to pay dividends; and (x) consolidate, merge or sell all or substantially all of its assets.

The Indenture contains customary events of default including, without limitation, failure to make required payments, failure to comply with certain agreements or covenants, cross-acceleration to certain other indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, and failure to pay certain judgments. An event of default under the Indenture will allow either the trustee or the holders of at least 25% in aggregate principal amount of the then outstanding Senior Notes to accelerate, or in certain cases, will automatically cause the acceleration of, the maturity of the principal, and accrued and unpaid interest, if any, on all outstanding Notes.

Debt issuance costs relating to the Senior Notes of $5.7 million, netted against the debt amount on the condensed consolidated balance sheet, are amortized as interest expense over 99 months. The total interest expense recorded on the Senior Notes during the three and nine months ended March 26, 2022 was $4.1 million and $12.4 million, respectively. The total interest expense recorded on the Senior Notes during the nine months ended March 27, 2021 was $0.9 million.

Revolving Credit Facility

On March 11, 2021, we entered into a Second Amended and Restated Credit Agreement, with the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent, or the Credit Agreement, to, among other changes, extend the maturity date of our senior secured revolving credit facility, to five years from the closing date of the amendment, increase the facility size from $200.0 million to $250.0 million, and replace the requirement to maintain a total debt to Consolidated EBITDA (as defined in the Credit Agreement) ratio of not more than 4.75 to 1.00 with a requirement to maintain a net total debt to Consolidated EBITDA

ratio of not more than 3.75 to 1.00 provided that for the four fiscal quarters ending after the date of a material acquisition, such maximum leverage ratio shall be adjusted to 4.25 to 1.00, and thereafter 3.75 to 1.00, provided further, that such deemed increase pursuant to the foregoing shall not apply to more than two material acquisitions consummated during the term of the Credit Agreement.

The Credit Agreement provides for a revolving credit facility in a principal amount of up to $250 million, which includes a $20 million sublimit for letters of credit and a $25 million sublimit for swingline loans. Under the terms of the Credit Agreement, we may, subject to the satisfaction of certain conditions, request increases in the revolving credit facility commitments in an aggregate principal amount of up to $150 million to the extent existing or new lenders agree to provide such increased or additional commitments, as applicable. Future proceeds under the revolving credit facility are available for working capital and general corporate purposes. In March 2021 we used a portion of the proceeds from the Senior Notes described above to repay the $100.0 million outstanding borrowings on this revolving credit facility. As of March 26, 2022, there was no balance outstanding under the revolving credit facility.

Borrowings under the revolving credit facility are required to be repaid in full by March 11, 2026. Debt issuance costs relating to the revolving credit facility of $1.6 million, included in non-current other assets on our consolidated balance sheet, are being amortized over 60 months.

Our obligations under the Credit Agreement are guaranteed by the material domestic subsidiaries of our company, subject to certain exceptions, who collectively with our company are referred to as the Credit Parties. The obligations of the Credit Parties under the Credit Agreement and the other loan documents delivered in connection therewith are secured by a first priority security interest in substantially all of the existing and future personal property of the Credit Parties, including, without limitation, 65% of the voting capital stock and 100% of the non-voting capital stock of certain of the Credit Parties’ direct foreign subsidiaries, subject to certain exceptions.

The revolving credit facility bears interest at our election of a Base Rate plus an Applicable Margin or LIBOR plus an Applicable Margin. Swingline loans bear interest at a Base Rate plus an Applicable Margin. The Base Rate is a floating rate that is the greater of the Prime Rate, the Federal Funds Rate plus 50 basis points, or LIBOR plus 100 basis points. The Applicable Margin is based on a sliding scale which ranges from 0.25 to 100 basis points for Base Rate loans and 100 basis points to 175 basis points for LIBOR loans. We are required to pay a commitment fee on any unused commitments under the Credit Agreement which is determined on a leverage-based sliding scale ranging from 0.175% to 0.25% per annum. Interest and fees are payable on a quarterly basis. The LIBOR index is expected to be discontinued at the end of June 2023. Under our credit facility, when the LIBOR index is discontinued, we will switch to a comparable or successor rate as selected by us and the administrative agent, which may include the Secured Overnight Financing Rate, or SOFR.

Under the Credit Agreement, there are various restrictive covenants, including two financial covenants which limit the consolidated total leverage ratio, or leverage ratio, the consolidated interest coverage ratio, or interest coverage ratio, a restriction that permits accounts receivable financings provided that the aggregate unpaid amount of permitted accounts receivable financings are no more than the greater of $100 million and 50% of the amount of all accounts receivable of the Company and specified subsidiaries and other specific items. The leverage ratio is the ratio of net debt as of the measurement date to Consolidated EBITDA, for the four consecutive quarters ending with the quarter of measurement. The current leverage ratio shall not exceed 3.75 to 1.00 provided that for the four fiscal quarters ending after the date of a material acquisition, such maximum leverage ratio shall be adjusted to 4.25 to 1.00, and thereafter 3.75 to 1.0. The interest coverage ratio is Consolidated EBITDA to interest expense for the four consecutive quarters ending with the quarter of measurement. The interest coverage ratio must not be less than 3.50 to 1.0 during the term of the Credit Agreement. As of March 26, 2022, we remain in compliance with the restrictive covenants.

Term Loan Facility

On December 2, 2021, we entered into that certain First Amendment and Lender Joinder Agreement to the Credit Agreement, to, among other things, establish a new $600.0 million incremental term loan facility, or the Term Loan Facility. The Term Loan Facility was advanced by certain existing and new lenders under the Credit Agreement to finance the DSPG acquisition. The Term Loan Facility matures on December 2, 2028. Principal on the Term Loan Facility is payable in equal quarterly installments on the last day of each March, June, September and December of each year, beginning December 31, 2021, at a rate of 1.00% per annum.

Borrowings under the Term Loan Facility will accrue interest at the London Interbank Offered Rate, or LIBOR, plus 2.25% or at the base rate plus 1.50%, subject to a 25 basis point step-down based on total gross leverage, and subject to a LIBOR floor of 50 basis points. The base rate is the highest of (i) the Federal Funds Rate plus 0.50%, (ii) the Wells Fargo Bank, National Association prime rate and (iii) the one-month LIBOR plus 1.00%. The Term Loan Facility contains customary representations and warranties, affirmative and negative covenants and events of default, in each case consistent with the Credit Agreement. The Term Loan Facility does not contain any financial covenant.

The Term Loan Facility is subject to a 1.00% prepayment premium in the event all or any portion of the Term Loan Facility is prepaid within the first 6 months in connection with a repricing transaction only. The Term Loan Facility is subject to customary mandatory prepayments, including, commencing with the fiscal year ending June 30, 2023, an excess cash flow sweep, subject to customary step-downs and thresholds.

Debt issuance costs relating to the Term Loan Facility of $11.2 million, netted against the debt amount on the condensed consolidated balance sheet, are amortized as interest expense over 96 months. The total interest expense recorded on the Term Loan during both the three and nine months ended March 26, 2022, was $4.5 million and $5.9 million, respectively.

Convertible Debt

On June 1, 2021, pursuant to the Indenture, dated as of June 26, 2017 between us and Wells Fargo Bank, National Association, as trustee, or the Convertible Notes Indenture, we provided an irrevocable notice of redemption, for all $525,000,000 aggregate principal amount of our outstanding 0.50% convertible senior notes due in 2022, or the Convertible Notes. The Convertible Notes were redeemable at a cash redemption price of 100.0% of the principal amount, plus accrued and unpaid interest, if any, to, but excluding, the redemption date of August 4, 2021.

Holders of the Convertible Notes had the right to convert the Convertible Notes called for redemption no later than August 3, 2021, or the Conversion Deadline. The conversion rate was equal to 13.7267 shares per $1,000 principal amount of the Convertible Notes, which was the initial conversion rate of 13.6947 shares per $1,000 principal amount of the Convertible Notes plus a number of additional shares equal to 0.0320 shares per $1,000 principal amount of the Convertible Notes. We elected to settle any conversions by Combination Settlement (as defined in the Convertible Notes Indenture) with a Specified Dollar Amount (as defined in the Convertible Notes Indenture) per $1,000 principal amount of Convertible Notes equal to $1,000, plus a number of shares of our common stock, to be determined pursuant to the Convertible Notes Indenture, together with additional cash, if applicable, in lieu of delivering any fractional shares of common stock. As a result of this election, on August 4, 2021, we settled or redeemed the remaining outstanding Convertible Notes for $505.6 million in cash representing the principal amount outstanding and delivered approximately 3.5 million shares in common stock from our treasury stock for additional amounts, resulting in a loss of approximately $8.1 million which is included in Interest and other expense, net on our condensed consolidated statements of income included elsewhere in this report.

12. Share-Based Compensation

Share-based compensation and the related tax benefit recognized in our condensed consolidated statements of income were as follows (in millions):


	Three Months Ended						Nine Months Ended
	March						March
	2022			2021			2022			2021
Cost of revenue	$	0.9		$	0.8		$	3.2		$	2.6
Research and development		18.0			12.9			57.4			33.4
Selling, general, and administrative		15.2			11.4			45.7			34.0
Total	$	34.1		$	25.1		$	106.3		$	70.0
Income tax benefit on share-based compensation	$	(3.4	)	$	(2.5	)	$	(20.1	)	$	(11.5	)

Included in the preceding table is share-based compensation for our cash-settled phantom stock units, which we granted in October 2019 (see Phantom Stock Units below) (in millions):


	Three Months Ended				Nine Months Ended
	March				March
	2022		2021		2022		2021
Cost of revenue	$	0.1	$	0.1	$	0.2	$	0.3
Research and development		6.4		7.2		26.7		16.4
Selling, general, and administrative		1.4		1.5		5.6		3.5
Total	$	7.9	$	8.8	$	32.5	$	20.2

Historically, we have issued new shares in connection with our equity-settled share-based compensation plans, however, treasury shares are also available for issuance. Any additional shares repurchased under our common stock repurchase program will be available for issuance under our share-based compensation plans.

Share-Based Compensation Plans

On October 29, 2019, our stockholders approved: (i) our 2019 Equity and Incentive Compensation Plan, or the 2019 Incentive Plan, to replace our Amended and Restated 2010 Incentive Compensation Plan, or the 2010 Incentive Plan, and (ii) our 2019 Employee Stock Purchase Plan, or the 2019 ESPP, to replace our Amended and Restated 2010 Employee Stock Purchase Plan. As of October 29, 2019, no new awards may be granted under the 2010 Incentive Plan or the Amended and Restated 2010 Employee Stock Purchase Plan. Awards outstanding at October 29, 2019 under our prior share-based compensation plans were not impacted by the approval of the 2019 Incentive Plan and continue to remain outstanding and vest by their terms under the applicable share-based compensation plan. Shares underlying certain share-based awards forfeited under the 2010 Incentive Plan subsequent to the approval of the 2019 Incentive Plan automatically transfer to and become available for award issuance from the 2019 Incentive Plan.

The 2019 Incentive Plan authorizes our Board of Directors to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, RSUs, cash incentive awards, performance shares, PSUs, and other stock-based awards. The 2019 Incentive Plan has been amended and restated twice, effective October 27, 2020 and October 26, 2021, respectively. The cumulative number of shares approved by stockholders under the 2019 Incentive Plan was 4,590,000 as of October 26, 2021. The 2019 ESPP authorizes the Company to provide eligible employees with an opportunity to acquire an equity interest in the Company through the purchase of stock at a discount, with an initial authorization of 1,500,000 shares.

Effective August 19, 2019, we adopted the 2019 Inducement Equity Plan, and 650,000 shares of our common stock were reserved for issuance under the 2019 Inducement Equity Plan, subject to adjustment for stock dividends, stock splits, or other changes in our common stock or capital structure. The 2019 Inducement Equity Plan was intended to comply with Rule 5635(c)(4) of the Nasdaq Stock Market Listing Rules, which provide an exception to the Nasdaq Stock Market Listing Rules on the shareholder approval requirement for the issuance of securities with regards to grants to employees of the Company or its subsidiaries as an inducement material to such individuals entering into employment with the Company or its subsidiaries. An individual was eligible to receive an award under the 2019 Inducement Equity Plan only if he or she was not previously an employee or director of our Company (or is returning to work after a bona-fide period of non-employment), and an award under the 2019 Inducement Equity Plan is a material inducement for him or her to accept employment with our Company. No new awards may be granted under the 2019 Inducement Equity Plan.

Stock Options

Stock option activity was as follows:


	Stock			Weighted		Aggregate
	Option			Average		Intrinsic
	Awards			Exercise		Value
	Outstanding			Price		(in millions)
Outstanding as of June 2021		55,061		$	66.68
Exercised		(22,300	)		73.30
Outstanding and Exercisable as of March 2022		32,761			62.18	$	5.1

The aggregate intrinsic value was determined using the closing price of our common stock on March 25, 2022 of $217.52.

Restricted Stock Units

Our 2019 Incentive Plan provides for the grant of RSUs to our employees, consultants, and directors with initial grants occurring in 2019, and previously our 2019 Inducement Equity Plan and our 2010 Incentive Plan provided for the grant of deferred stock units, or DSUs, to our employees, consultants, and directors with initial grants occurring in 2006. An RSU and a DSU are each a promise to deliver shares of our common stock at a future date in accordance with the terms of the grant agreement and the words can be used interchangeably. Accordingly, any reference to RSU is intended to signify both an RSU and a DSU.

RSUs granted generally vest ratably over three to four years from the vesting commencement date.

RSU activity was as follows:


				Aggregate
	RSU			Intrinsic
	Awards			Value
	Outstanding			(in millions)
Balance as of June 2021		1,323,286
Granted		602,320
Delivered		(549,596	)
Forfeited		(147,461	)
Balance as of March 2022		1,228,549		$	267.2

The aggregate intrinsic value was determined using the closing price of our common stock on March 25, 2022 of $217.52.

On the delivery date, we withhold shares to cover statutory tax withholding requirements and deliver a net quantity of shares to the recipient after such withholding. Until delivery of shares, the grantee has no rights as a stockholder with respect to any shares underlying the RSU award. Of the shares delivered, 162,082 shares valued at $30.2 million were withheld to meet statutory tax withholding requirements.

Market Stock Units

Our 2019 Incentive Plan, and previously our 2019 Inducement Equity Plan provide for the grant of MSU awards to our employees, consultants, and directors. An MSU is a promise to deliver shares of our common stock at a future date based on the achievement of market-based performance requirements in accordance with the terms of the MSU grant agreement.

We have granted MSU awards to our executive officers and other management members under our 2010 Incentive Plan, our 2019 Incentive Plan, and our 2019 Inducement Equity Plan, which are designed to vest in three or four tranches with the target quantity for each tranche equal to one-third or one-fourth of the total MSU grant. The first tranche vests based on a one-year performance period; the second tranche vests based on a two-year performance period; the third tranche vests based on a three-year performance period; and the fourth tranche (in the case of four-year vesting) vests based on a four-year performance period.

For MSU awards granted after fiscal 2020, performance is measured based on our achievement of a specified level of total stockholder return, or TSR, relative to the TSRs of each company in the Russell 2000 Index. The potential payout ranges from 0% to 200% of the target grant quantity based on our TSR performance relative to the TSRs of each company in the Russell 2000 Index. No payout will occur if our TSR performance falls below the 25th percentile of the TSRs of each company in the Russell 2000 Index, and a 200% payout will occur if our TSR performance exceeds the 75th percentile of the TSRs of each company in the Russell 2000 Index. Performance payouts between the 25th and 75th percentiles will be determined on a linear basis with performance at the 50th percentile equal to 100% of target.

For MSU awards granted after fiscal 2020, the first tranche and the second tranche can payout up to 200%, and the payout for the third tranche will be calculated based on the total target quantity for the entire grant multiplied by the payout factor, based on performance for the three-year performance period, less shares issued for the first tranche and the second tranche.

For MSU awards granted prior to fiscal 2021, performance is measured based on our achievement of a specified level of TSR relative to the TSR of the S&P Semiconductor Select Industry Index, or SPSISC Index. The potential payout ranges from 0% to 200% of the target grant quantity and is adjusted on a two-to-one ratio based on our TSR performance relative to SPSISC Index TSR.

For MSU awards granted prior to fiscal 2021 and vesting over three years, the payout for the first tranche and the second tranche will not exceed 100% and the payout for the third tranche will be calculated based on the total target quantity for the entire grant multiplied by the payout factor, based on performance for the three-year performance period, less shares issued for the first tranche and the second tranche. For MSUs vesting over four years, the payout for the first tranche, the second tranche and the third tranche will not exceed 100% and the payout for the fourth tranche will be calculated based on the total target quantity for the entire grant multiplied by the payout factor, based on performance for the four-year performance period, less shares issued for the first tranche, the second tranche and the third tranche.

Delivery of shares earned, if any, will take place on the dates provided in the applicable MSU grant agreement, assuming the grantee is still an employee, consultant, or director of our Company at the end of the applicable performance period.

MSU activity was as follows:


				Aggregate
	MSU			Intrinsic
	Awards			Value
	Outstanding			(in millions)
Balance as of June 2021		347,027
Granted		134,728
Delivered		(203,883	)
Forfeited		(25,898	)
Balance as of March 2022		251,974		$	54.8

The aggregate intrinsic value was determined using the closing price of our common stock on March 25, 2022 of $217.52.

On the delivery date, we withhold shares to cover statutory tax withholding requirements and deliver a net quantity of shares to the recipient after such withholding. Until delivery of shares, the grantee has no rights as a stockholder with respect to any shares underlying the MSU award. Of the shares delivered, 105,719 shares valued at $18.3 million were withheld to meet statutory tax withholding requirements.

We value MSUs using the Monte Carlo simulation model on the date of grant and amortize the compensation expense over the three- or four-year performance and service period on a ratable basis by tranche. The unrecognized share-based compensation cost of our outstanding MSUs was approximately $19.8 million as of March 26, 2022, which will be recognized over a weighted average period of approximately 1.0 years.

Performance Stock Units

Our 2019 Incentive Plan, our 2010 Incentive Plan and our 2019 Inducement Equity Plan provide for the grant of PSU awards to our employees, consultants, and directors. A PSU is a promise to deliver shares of our common stock at a future date based on the achievement of performance-based requirements in accordance with the terms of the PSU grant agreement.

We have granted PSUs to our executive officers and other management members under our 2010 Incentive Plan, our 2019 Incentive Plan and our 2019 Inducement Equity Plan, which are designed to vest in three tranches with the target quantity for each tranche equal to one-third of the total PSU grant. Generally, the grants have a specific one-year performance period and vesting occurs over three service periods with the final service period ending approximately three years from the grant date. Performance is measured based on the achievement of a specified level of certain performance criteria (for PSUs granted in fiscal 2021 it is based on a combination of our design win revenue, non-GAAP gross margin percentage and non-GAAP operating expenses and for the PSUs granted prior to fiscal 2021 and during fiscal 2022 it is based on non-GAAP earnings per share). The potential payout ranges from 0% to 200% of the target grant quantity and is adjusted on a linear basis with a payout triggering if our measurement result equals greater than 75% of the target with a maximum payout achieved at 125% of target.

Delivery of shares earned, if any, will take place on the dates provided in the applicable PSU grant agreement, assuming the grantee is still an employee, consultant, or director of our Company at the end of the applicable service period.

PSU activity was as follows:


				Aggregate
	PSU			Intrinsic
	Awards			Value
	Outstanding			(in millions)
Balance as of June 2021		317,392
Awarded		185,676
Released		(208,023	)
Forfeited		(37,142	)
Balance as of March 2022		257,903		$	56.1

The aggregate intrinsic value was determined using the closing price of our common stock on March 25, 2022 of $217.52.

On the delivery date, we withhold shares to cover statutory tax withholding requirements and deliver a net quantity of shares to the recipient after such withholding. Until delivery of shares, the grantee has no rights as a stockholder with respect to any shares underlying the PSU award. Of the shares delivered, 94,642 shares valued at $17.6 million were withheld to meet statutory tax withholding requirements.

We value PSUs using the aggregate intrinsic value on the date of grant adjusted for estimated performance achievement during the performance period and amortize the compensation expense over the three-year service period on a ratable basis. The unrecognized share-based compensation cost of our outstanding PSUs was approximately $23.5 million as of March 26, 2022, which will be recognized over a weighted average period of approximately 1.0 years.

Phantom Stock Units

The 2019 Incentive Plan authorizes the grant of phantom stock units to non-employee directors, officers and employees. We initially granted phantom stock units to certain non-officer employees in October 2019 and there have been no subsequent phantom stock unit grants. Phantom stock units are cash-settled and entitle the recipient to receive a cash payment equal to the value of a single share for each unit based on the average closing share price of our stock over the thirty calendar days prior to the vesting date. Grants of phantom stock units vest over three years, with an annual vesting date of October 31 each year subsequent to the grant date. We recognize compensation expense for phantom stock units on a straight-line basis for each tranche of each award based on the average closing price of our common stock over the thirty calendar days ended prior to each balance sheet date. The outstanding phantom stock units had a fair value of $218.56 per unit at March 26, 2022 and our accrued liability for such units was $15.7 million.

Phantom stock activity was as follows:



	Phantom
	Stock Units
	Outstanding
Balance as of June 2021		402,458
Released		(196,420	)
Forfeited		(25,845	)
Balance as of March 2022		180,193

Employee Stock Purchase Plan

Shares purchased, weighted average purchase price, cash received, and the aggregate intrinsic value for employee stock purchase plan purchases during the nine months ended March 26, 2022 were as follows (in millions, except for shares purchased and weighted average price):


Shares purchased		138,502
Weighted average purchase price	$	97.91
Cash received	$	13.6
Aggregate intrinsic value	$	12.5

13. Income Taxes

We account for income taxes under the asset and liability method. The provision for income taxes recorded in interim periods is based on our estimate of the annual effective tax rate applied to year-to-date income before provision for income taxes, adjusted for discrete items required to be recognized in the period in which they are incurred. In each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, we make a cumulative adjustment in that quarter. Our quarterly tax provision and our quarterly estimate of the annual effective tax rate can be subject to volatility due to several factors, including our ability to accurately forecast annual income before provision for income taxes in each of the tax jurisdictions in which we operate.

The provision for income taxes of $24.4 million and $10.4 million for the three months ended March 26, 2022 and March 27, 2021, respectively, represented estimated federal, foreign, and state income taxes. The effective tax rate for the three months ended March 26, 2022 diverged from the combined U.S. federal and state statutory tax rate primarily because of the benefit of income taxed at lower rates, research credits and foreign tax credits, partially offset by foreign withholding taxes, non-deductible officer compensation and global intangible low-taxed income, or GILTI. The effective tax rate for the three months ended March 27, 2021, diverged from the combined U.S. federal and state statutory tax rate, primarily because of income taxed at lower rates, the benefit of research credits and foreign tax credits, partially offset by foreign withholding taxes and GILTI.

The provision for income taxes of $32.3 million and $16.4 million for the nine months ended March 26, 2022 and March 27, 2021, respectively, represented estimated federal, foreign, and state income taxes. The effective tax rate for the nine months ended March 26, 2022 diverged from the combined U.S. federal and state statutory tax rate primarily because of income taxed at lower rates, the benefit of research credits and foreign tax credits, partially offset by foreign withholding taxes, non-deductible officer compensation and GILTI. The effective tax rate for the nine months ended March 27, 2021, diverged from the combined U.S. federal and state statutory tax rate, primarily because of the benefit of income taxed at lower rates, research credits and foreign tax credits, partially offset by foreign withholding taxes and GILTI.

The total liability for gross unrecognized tax benefits related to uncertain tax positions increased $14.4 million during the nine months ended March 26, 2022, to $37.0 million, and was included in other long-term liabilities on our condensed consolidated balance sheets. If recognized, the total gross unrecognized tax benefits would reduce the effective tax rate on income from continuing operations. Accrued interest and penalties related to unrecognized tax benefits as of March 26, 2022 were $2.7 million; this balance increased by $1.0 million compared to June 26, 2021. We classify interest and penalties as components of income tax expense. Any prospective adjustments to our unrecognized tax benefits will be recorded as an increase or decrease to income tax expense and cause a corresponding change to our effective tax rate. Accordingly, our effective tax rate could fluctuate materially from period to period.

Our major tax jurisdictions are the United States, Hong Kong SAR, Israel, Japan and the United Kingdom. From fiscal 2014 onward, we remain subject to examination by one or more of these jurisdictions.

In January 2022, final foreign tax credit regulations were issued by the U.S. Treasury modifying long established rules, including rules used in the determination of whether foreign taxes paid or accrued are creditable against U.S. income taxes. We are evaluating these new regulations and certain research and development capitalization rule changes, all effective beginning with our fiscal 2023, but anticipate our future provision for income taxes will be adversely affected.

14. Segment, Customers, and Geographic Information

We operate in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. We generate our revenue from three broad product categories: the IoT product market, the personal computing, or PC, product market, and the Mobile product market. We sell our products to OEMs and to contract manufacturers that provide manufacturing services to OEMs.

Net revenue within geographic areas based on our customers’ locations for the periods presented was as follows (in millions):


	Three Months Ended				Nine Months Ended
	March				March
	2022		2021		2022		2021
China	$	171.2	$	130.9	$	448.4	$	406.2
Taiwan		140.1		101.5		387.3		268.1
Japan		127.9		67.5		339.0		258.9
Other		17.4		16.7		50.6		54.7
South Korea		8.6		8.5		27.5		20.0
United States		4.9		0.7		10.5		3.9
	$	470.1	$	325.8	$	1,263.3	$	1,011.8

Net revenue from our customers for each product category was as follows (in millions):


	Three Months Ended				Nine Months Ended
	March				March
	2022		2021		2022		2021
IoT product applications	$	301.6	$	151.4	$	768.8	$	435.0
PC product applications		90.1		98.4		261.4		270.4
Mobile product applications		78.4		76.0		233.1		306.4
	$	470.1	$	325.8	$	1,263.3	$	1,011.8

A reclassification has been made to the prior periods revenue presentation in the above table in order to conform to the current period revenue presentation. The reclassification of $5.4 million and $19.5 million during the three and nine months ended March 2021, respectively, moved virtual reality product revenue from Mobile product applications to IoT product applications.

Net revenue from major customers as a percentage of total net revenue for the periods presented was as follows:


	Three Months Ended		Nine Months Ended
	March		March
	2022	2021		2022	2021
Customer A	14%	13%		13%	12%
Customer B	14%	11%		13%	11%
Customer C	*	*		*	16%

____________________

* Less than 10%

We extend credit based on evaluation of a customer’s financial condition, and we generally do not require collateral. Major customer accounts receivable as a percentage of total accounts receivable were as follows:


	March	June
	2022	2021

Customer A	21%	15%
Customer B	10%	12%
Customer C	10%	*

15. Comprehensive Income

Our comprehensive income generally consists of unrealized gains or losses on our available-for-sale securities. We recognize foreign currency remeasurement adjustments and foreign currency transaction gains and losses in our condensed consolidated statements of income as the U.S. dollar is the functional currency of our foreign entities.

16. Restructuring Activities

During fiscal 2022, we initiated restructuring activities which were for activities intended to further improve efficiencies in our operational activities. The restructuring costs related to these activities were recorded to the restructuring costs line item within our condensed consolidated statements of income. These activities are expected to be complete by the end of fiscal 2022. The restructuring liability activity for these restructuring activities during fiscal 2022 was as follows (in millions):


	Employee Severance
	and Benefits
Balance, June 26, 2021	$	-
Accruals		2.6
Cash payments		(1.1	)
Balance, March 26, 2022	$	1.5

During the second quarter of fiscal 2022, we initiated restructuring activities, which included severance costs for activities intended to gain synergies from the DSPG acquisition as well as accelerated vesting on equity awards. The restructuring costs related to these activities were recorded to the restructuring costs line item within our condensed consolidated statements of income, and the restructuring activities are expected to be complete by the end of fiscal 2022. The restructuring liability activity for these restructuring activities during fiscal 2022 was as follows (in millions):


	Employee Severance
	and Benefits
Balance, June 26, 2021	$	-
Accruals		7.6
Accelerated vesting on equity awards		7.6
Cash payments		(12.1	)
Balance, March 26, 2022	$	3.1

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements and Factors That May Affect Results

This Quarterly Report on Form 10-Q for the quarter ended March 26, 2022 (this “Report”) contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business, including our expectations regarding the potential impacts on our business of the COVID-19 pandemic, and can be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements may include words such as “expect,” “anticipate,” “intend,” “believe,” “estimate,” “plan,” “target,” “strategy,” “continue,” “may,” “will,” “should,” variations of such words, or other words and terms of similar meaning. All forward-looking statements reflect our best judgment and are based on several factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Such factors include, but are not limited to the following: our dependence on our solutions for the mobile product applications market and the PC product applications market for a substantial portion of our revenue; risks related to the volatility of our net revenue from our solutions for mobile product applications; our dependence on one or more large customers; the risk that our business, results of operations and financial condition (including liquidity) and prospects may be materially and adversely affected by health epidemics, including the COVID-19 pandemic; our exposure to industry downturns and cyclicality in our target markets; the risk that our product solutions for new markets will not be successful; global supply chain disruptions and component shortages that are currently affecting the semiconductor industry as a whole; our ability to maintain and build relationships with our customers; our dependence on third parties to maintain satisfactory manufacturing yields and deliverable schedule; and the risks as identified in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business” sections of our Annual Report on Form 10-K for the fiscal year ended June 26, 2021, and other risks as identified from time to time in our SEC reports. Forward-looking statements are based on information available to us on the date hereof, and we do not have, and expressly disclaim, any obligation to publicly release any updates or any changes in our expectations, or any change in events, conditions, or circumstances on which any forward-looking statement is based. Our actual results and the timing of certain events could differ materially from the forward-looking statements. These forward-looking statements do not reflect the potential impact of any mergers, acquisitions, or other business combinations that have not been completed as of the date of this filing.

Statements made in this Report, unless the context otherwise requires, include the use of the terms “us,” “we,” “our,” the “Company” and “Synaptics” to refer to Synaptics Incorporated and its consolidated subsidiaries.

Impact of COVID-19

On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a global pandemic. In response to the outbreak, governmental authorities implemented numerous containment measures, including travel bans and restrictions, quarantines, shelter-in-place orders, and business restrictions and shutdowns, resulting in rapidly changing market and economic conditions. In certain countries in which we operate, governments took swift and effective measures to stem the spread, while in other countries in which we operate governments were slow to react or missed opportunities to effectively contain the spread. Although some of these restrictions and other containment measures have since been lifted or scaled back, ongoing surges of COVID-19 have resulted in the re-imposition of certain restrictions and containment measures and may lead to other restrictions being re-implemented in the future in response to efforts to reduce the rapid spread of COVID-19 and its variants.

The health and wellbeing of our workforce is our highest priority. Many of our employees have worked from home at times during the COVID-19 pandemic in order to minimize the potential risk of spread of COVID-19 in our office environment, or as required by local governments, including ongoing mandatory lockdowns and forced quarantines in Shanghai. Many employees who have been fully vaccinated have returned to the office environment on a part- or full-time basis, where permitted. As more employees return to the office, we will continue to adhere to return to work protocols, based on guidance from local and global health organizations and applicable laws and regulations.

While the severity and duration of business disruption to our customers and suppliers due to the COVID-19 pandemic continues to remain uncertain, we expect that the ongoing global vaccination programs will continue to moderate the overall severity and duration and remain optimistic the most significant impact has passed. As more COVID-19 variants continue to emerge, some of which may be more infectious and may have greater resistance to the existing vaccines, we could experience episodes of renewed and sustained business disruption. To date, we have not incurred significant disruptions to our business or a materially negative impact on our condensed consolidated results of operations and financial condition from the COVID-19 outbreak, and we continue to believe our business will not be severely impacted as steps continue to be taken globally to mitigate the spread, vaccinate large portions of the population and achieve herd immunity.

We will continue to evaluate the nature and scope of the impact of COVID-19 to our business, consolidated results of operations, and financial condition and may take further actions altering our business operations and managing our costs and liquidity

that we deem necessary or appropriate to respond to this fast moving and uncertain global health crisis and the resulting global economic consequences.

Overview

We are a leading worldwide developer and supplier of custom-designed semiconductor solutions that is changing the way humans engage with connected devices and data, engineering exceptional experiences throughout the home, at work, in the car and on the go. Our current served markets include Internet of Things, or IoT, personal computer, or PC, and Mobile. We deliver complete chip, firmware and software semiconductor solutions that include connectivity products, audio input and output System-On-Chips, or SoCs, high-definition video and vision SoCs, SoCs with artificial intelligence capabilities, touch controllers, touchpads, display drivers and fingerprint biometric sensors.

We are a market leader in providing premium mixed signal semiconductor solutions to our target markets. Our Original Equipment Manufacturer, or OEM, customers include many of the world’s largest OEMs for smart home devices, automotive solutions, notebook computers and peripherals, smartphones and tablets, and many large OEMs for audio and video products. We generally supply our product solutions to our OEM customers through their contract manufacturers, which take delivery of our products and pay us directly for such products.

Our manufacturing operations are based on a variable cost model in which we outsource all of our production requirements and generally drop ship our products directly to our customers from our contract manufacturers’ facilities, eliminating the need for significant capital expenditures and allowing us to minimize our investment in inventories. This approach requires us to work closely with our contract manufacturers and semiconductor fabricators to ensure adequate production capacity to meet our forecasted volume requirements. As a result of recent supply constraints and capacity shortages affecting the global semiconductor industry, we have entered into long-term capacity and pricing agreements with some suppliers. We use third-party wafer manufacturers to supply wafers and third-party packaging manufacturers to package our proprietary application specific integrated circuits, or ASICs. In certain cases, we rely on a single source or a limited number of suppliers to provide other key components of our products. Our cost of revenue includes all costs associated with the production of our products, including materials; logistics; amortization of intangibles related to acquired developed technology; backlog; supplier arrangements; manufacturing, assembly, and test costs paid to third-party manufacturers; and related overhead costs associated with our indirect manufacturing operations personnel. Additionally, we charge all warranty costs, losses on inventory purchase obligations, and write-downs to reduce the carrying value of obsolete, slow moving, and non-usable inventory to net realizable value, to cost of revenue.

Our gross margin generally reflects the combination of the added value we bring to our OEM customers’ products by meeting their custom design requirements and the impact of our ongoing cost-improvement programs. These cost-improvement programs include reducing materials and component costs and implementing design and process improvements. Our newly introduced products may have lower margins than our more mature products, which have realized greater benefits associated with our ongoing cost-improvement programs. As a result, new product introductions may initially negatively impact our gross margin.

Our research and development expenses include costs for supplies and materials related to product development, as well as the engineering costs incurred to design ASICs and human experience solutions for OEM customers prior to and after our OEMs’ commitment to incorporate those solutions into their products. In addition, we expense in-process research and development projects acquired as part of a business acquisition, which have not yet reached technological feasibility, and which have no foreseeable alternative future use. We continue to commit to the technological and design innovation required to maintain our position in our existing markets, and to adapt our existing technologies or develop new technologies for new markets.

Selling, general, and administrative expenses include expenses related to sales, marketing, and administrative personnel; internal sales and outside sales representatives’ commissions; market and usability research; outside legal, accounting, and consulting costs; and other marketing and sales activities.

Acquired intangibles amortization, included in operating expenses, consists primarily of amortization of customer relationship and tradenames intangible assets recognized under the purchase method for business combinations.

Restructuring costs primarily reflect severance costs related to the restructuring of our operations to reduce operating expenses. These headcount related costs were in cost of revenue, research and development, and selling, general and administrative expenses.

Interest and other expense, net, primarily reflects loss on extinguishment of debt as discussed in Note 11 Debt to the condensed consolidated financial statements contained elsewhere in this Report, interest expense on our senior notes, convertible notes and revolving line of credit as well as the amortization of debt issuance costs and discount on our convertible notes, partially offset by interest income earned on our cash, cash equivalents and short-term investments.

The gain from the sale of our equity investment in OXI Technology Ltd., was recorded as part of the equity investment gain (loss) in the condensed consolidated statements of income.

Acquisitions

DSP Group, Inc.

On August 30, 2021, we entered into an agreement and plan of merger with DSP Group, Inc, or DSPG, to acquire all of the equity of DSPG for $22.00 per share of common stock. The transaction closed on December 2, 2021. As of March 26, 2022, our preliminary purchase consideration was $543.3 million, net of measurement period adjustments.

We financed the transaction through a combination of cash on hand and a new $600.0 million incremental term loan facility under our existing senior credit facility.

The results of DSPG are included in our condensed consolidated financial statements for the periods from December 3, 2021.

DisplayLink

On July 17, 2020, we entered into a definitive agreement to acquire all of the equity interests in DisplayLink Corporation, or DisplayLink, a leader in high-performance video compression technology. The acquisition closed on July 31, 2020. Our purchase consideration was $444.0 million. The results of DisplayLink are included in our condensed consolidated financial statements for the periods from August 1, 2020.

Broadcom

On July 2, 2020, we entered into definitive agreements with Broadcom, Inc., or Broadcom, to acquire certain assets and assume certain liabilities of, and obtain non-exclusive licenses relating to, Broadcom’s existing Wi-Fi, Bluetooth and GPS/GNSS products and business in the IoT market, or Broadcom Business Acquisition, for an aggregate consideration of $250 million in cash which closed on July 23, 2020. We also entered into certain transition agreements with Broadcom for a period of three years. The results of the Broadcom Business Acquisition are included in our condensed consolidated financial statements for periods from July 24, 2020.

Divestitures

In December 2020, we completed the sale of limited audio technology intangible assets, received a fully-paid up perpetual license back from the buyer and, as an element of the transaction licensed other audio technology intangible assets to the buyer under a fully-paid up perpetual license arrangement. Under the asset purchase agreement and the intellectual property license agreement, we received $35.0 million in cash. The gain on the sale of the audio technology assets was $34.2 million.

Critical Accounting Policies and Estimates

There have been no significant changes in our critical accounting policies and estimates during the nine months ended March 26, 2022, compared with our critical accounting policies and estimates disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended June 26, 2021.

Trends and Uncertainties

Supply Chain

The availability of various products is dependent on our suppliers, their locations, and the extent to which they are impacted by logistical constraints, local COVID-19 protocols, or their allocation of available supply to us. We continue to monitor and proactively work with our supply chain partners to secure capacity to meet end-customer demand. Further, during fiscal 2022 we have seen input price increases from our supply chain partners; however, we have worked closely with many of our customers to pass-through these increases in a manner that has not materially impacted our results of operations for the three and nine months ended March 26, 2022.

Workforce

The ability to hire and secure critical hardware and software engineers to expand our research and development activities is currently constrained in many of the geographic markets in which we operate. The competition for available engineering talent has intensified for a variety of reasons resulting in wage inflation in the semiconductor development industry. Our ability to attract and retain skilled employees is critical to the long-term growth and success of our business.

Results of Operations

Beginning in fiscal 2022, we are accounting for virtual reality revenue in IoT product applications rather than Mobile product applications. To conform the prior period revenue presentation to the current period revenue presentation, we reclassified $5.4 million and $19.5 million of virtual reality product revenue from Mobile product applications to IoT product applications for the three and nine months ended March 27, 2021, respectively. Certain of the data used in our condensed consolidated statements of income for the periods indicated, together with comparative absolute and percentage changes in these amounts, were as follows (in millions, except percentages):


	Three Months Ended March												Nine Months Ended March
	2022			2021			$ Change			% Change			2022			2021			$ Change			% Change
IoT product applications	$	301.6		$	151.4		$	150.2			99.2	%	$	768.8		$	435.0		$	333.8			76.7	%
PC product applications		90.1			98.4			(8.3	)		(8.4	%)		261.4			270.4			(9.0	)		(3.3	%)
Mobile product applications		78.4			76.0			2.4			3.2	%		233.1			306.4			(73.3	)		(23.9	%)
Net revenue		470.1			325.8			144.3			44.3	%		1,263.3			1,011.8			251.5			24.9	%
Gross margin		253.8			155.5			98.3			63.2	%		677.0			440.4			236.6			53.7	%
Operating expenses:
Research and development		98.2			77.5			20.7			26.7	%		273.2			235.7			37.5			15.9	%
Selling, general, and administrative		44.2			36.8			7.4			20.1	%		130.1			111.6			18.5			16.6	%
Acquired intangibles amortization		12.0			8.7			3.3			37.9	%		29.6			24.1			5.5			22.8	%
Restructuring costs		11.3			0.9			10.4			1156	%		17.8			7.1			10.7			150.7	%
Gain on sale of audio technology assets		-			-			-			0.0	%		-			(34.2	)		34.2			100.0	%
Operating income		88.1			31.6			56.5			178.8	%		226.3			96.1			130.2			135.5	%
Interest and other expense, net		(6.7	)		(7.0	)		0.3			4.3	%		(18.3	)		(17.7	)		(0.6	)		(3.4	%)
Gain from sale and leaseback		5.4			-			5.4			100.0	%		5.4			-			5.4			100.0	%
Loss on redemption of convertible notes		-			-			-			-			(8.1	)		-			(8.1	)	-
Income before provision for income taxes		86.8			24.6			62.2			252.8	%		205.3			78.4			126.9			161.9	%
Provision for income taxes		24.4			10.4			14.0			134.6	%		32.3			16.4			15.9			97.0	%
Equity investment loss		2.5			(0.4	)		2.9			725.0	%		1.6			(1.4	)		3.0			214.3	%
Net income	$	64.9		$	13.8		$	51.1			370.3	%	$	174.6		$	60.6		$	114.0			188.1	%

Certain of the data used in our condensed consolidated statements of income presented here as a percentage of net revenue for the periods indicated were as follows:


	Three Months Ended						Percentage Point			Nine Months Ended						Percentage Point
	March						Increase/			March						Increase/
	2022			2021			(Decrease)			2022			2021			(Decrease)
IoT product applications		64.2	%		46.5	%		17.7	%		60.9	%		43.0	%		17.9	%
PC product applications		19.2	%		30.2	%		(11.0	%)		20.7	%		26.7	%		(6.0	%)
Mobile product applications		16.7	%		23.3	%		(6.6	%)		18.4	%		30.3	%		(11.9	%)
Net revenue		100.1	%		100.0	%		0.1	%		100.0	%		100.0	%		0.0	%
Gross margin		54.0	%		47.7	%		6.3	%		53.6	%		43.5	%		10.1	%
Operating expenses:
Research and development		20.9	%		23.8	%		(2.9	%)		21.6	%		23.3	%		(1.7	%)
Selling, general, and administrative		9.4	%		11.3	%		(1.9	%)		10.3	%		11.0	%		(0.7	%)
Acquired intangibles amortization		2.6	%		2.7	%		(0.1	%)		2.3	%		2.4	%		(0.1	%)
Restructuring costs		2.4	%		0.3	%		2.1	%		1.4	%		0.7	%		0.7	%
Gain on sale of audio technology assets		0.0	%		0.0	%		0.0	%		0.0	%		(3.4	%)		3.4	%
Operating income		18.7	%		9.7	%		9.0	%		17.9	%		9.5	%		8.4	%
Interest and other expense, net		(1.4	%)		(2.1	%)		0.7	%		(1.4	%)		(1.7	%)		0.3	%
Gain from sale and leaseback		1.1	%		0.0	%		1.1	%		0.4	%		0.0	%		0.4	%
Loss on redemption of convertible notes		0.0	%		0.0	%		0.0	%		(0.6	%)		0.0	%		(0.6	%)
Income before provision for income taxes		18.5	%		7.6	%		10.9	%		16.3	%		7.7	%		8.6	%
Provision for income taxes		5.2	%		3.2	%		2.0	%		2.6	%		1.6	%		1.0	%
Equity investment loss		0.5	%		(0.1	%)		0.6	%		0.1	%		(0.1	%)		0.2	%
Net income		13.8	%		4.2	%		9.6	%		13.8	%		6.0	%		7.8	%

Net Revenue

Net revenue was $470.1 million for the three months ended March 26, 2022, compared with $325.8 million for the three months ended March 27, 2021, an increase of $144.3 million, or 44.3%. Of this net revenue, $301.6 million, or 64.2%, was from IoT product applications, $90.1 million, or 19.2%, was from PC product applications, and $78.4 million, or 16.7%, was from Mobile product applications. The increase in net revenue for the three months ended March 26, 2022 was primarily attributable to an increase in net revenue from IoT and Mobile product applications, partially offset by a decrease in net revenue from PC product applications. Net revenue from IoT product applications increased as a result of an increase in units sold (which increased 66%) as well as higher average selling prices (which increased 19.9%) due to product sales mix. Net revenue from PC product applications decreased due to a decline in units sold related to certain end customers' supply chain constraints (which decreased 30.6%) and partially offset by higher average selling prices (which increased 31.9%) due to our product sales mix. Net revenue from Mobile product applications increased due to higher average selling prices (which increased 12.4%) and partially offset by a decline in units sold (which decreased 8.2%).

Net revenue was $1,263.3 million for the nine months ended March 26, 2022, compared with $1,011.8 million for the nine months ended March 27, 2021, an increase of $251.5 million, or 24.9%. Of this net revenue, $768.8 million, or 60.9%, was from IoT product applications, $261.4 million, or 20.7%, was from PC product applications, and $233.1 million, or 18.4%, was from Mobile product applications. The increase in net revenue for the nine months ended March 26, 2022 was primarily attributable to an increase in net revenue from IoT product applications, partially offset by a decrease in net revenue from PC and Mobile product applications. Net revenue from IoT product applications increased as a result of an increase in units sold (which increased 34.4%) as well as higher average selling prices (which increased 31.5%) due to product sales mix. Net revenue from PC product applications decreased due to a decline in units sold (which decreased 19.4%) partially offset by higher average selling prices (which increased 19.9%) due to our product sales mix. Net revenue from Mobile product applications decreased due to a decline in units sold (which decreased 25.2%) for Mobile product applications partially offset by higher average selling prices (which increased 1.7%) due to our product sales mix.

Gross Margin

Gross margin as a percentage of net revenue was 54.0%, or $253.8 million, for the three months ended March 26, 2022, compared with 47.7%, or $155.5 million, for the three months ended March 27, 2021. The 630 basis point increase in gross margin for

the three months ended March 26, 2022, was due to an overall favorable product mix and an increase in average sales prices partially offset by a $9.2 million increase in acquired intangibles amortization and inventory fair value adjustments included in cost of revenue.

Gross margin as a percentage of net revenue was 53.6% or $677.0 million, for the nine months ended March 26, 2022, compared with 43.5%, or $440.4 million, for the nine months ended March 27, 2021. The 1,010 basis point increase in gross margin for the nine months ended March 26, 2022, was due to an overall favorable product mix driven and an increase in average sales prices as well as a $13.2 million decrease in acquired intangibles amortization and inventory fair value adjustments included in cost of revenue.

Because we sell our technology solutions in designs that are generally unique or specific to an OEM customer’s application, gross margin varies on a product-by-product basis, making our cumulative gross margin a blend of our product specific designs. As a fabless manufacturer, our gross margin percentage is generally not materially impacted by our shipment volume. We charge losses on inventory purchase obligations and write-downs to reduce the carrying value of obsolete, slow moving, and non-usable inventory to net realizable value (including warranty costs) to cost of revenue.

Operating Expenses

Research and Development Expenses. Research and development expenses increased $20.7 million to $98.2 million for the three months ended March 26, 2022, compared with $77.5 million for the three months ended March 27, 2021. The increase in research and development expenses primarily reflected a $5.1 million increase in share-based compensation costs primarily related to an increased stock price which impacted the value of the new grants and the phantom stock units accrual and an increase in payroll and variable compensation costs of $10.8 million, which includes costs associated with research and development headcount from our DSPG acquisition, which closed on December 2, 2021.

Research and development expenses increased $37.5 million to $273.2 million for the nine months ended March 26, 2022, compared with $235.7 for the nine months ended March 27, 2021. The increase in research and development expenses primarily reflected a $24.0 million increase in share-based compensation costs primarily related to an increased stock price which impacted the value of the new grants and the phantom stock units accrual, an increase in payroll and variable compensation costs of $13.3 million, which includes costs associated with research and development headcount from our DSPG acquisition, which closed on December 2, 2021.

Selling, General, and Administrative Expenses. Selling, general, and administrative expenses increased $7.4 million to $44.2 million for the three months ended March 26, 2022, compared with $36.8 million for the three months ended March 27, 2021. The increase in selling, general, and administrative expenses primarily reflected a $3.8 million increase in share-based compensation costs primarily related to an increased stock price which impacted the value of the new grants and the phantom stock units accrual and an increase in payroll and variable compensation costs of $2.8 million, which includes costs associated with additional selling, general, and administrative headcount from our DSPG acquisition, which closed on December 2, 2021.

Selling, general, and administrative expenses increased $18.5 million to $130.1 million for the nine months ended March 26, 2022, compared with $111.6 million for the nine months ended March 27, 2021. The increase in selling, general, and administrative expenses primarily reflected a $11.7 million increase in share-based compensation costs primarily related to an increased stock price which impacted the value of the new grants and the phantom stock units accrual and an increase in payroll and variable compensation costs of $6.0 million, which includes costs associated with additional selling, general, and administrative headcount from our DSPG acquisition, which closed on December 2, 2021.

Acquired Intangibles Amortization. Acquired intangibles amortization reflects the amortization of intangibles acquired through acquisitions. For further discussion of acquired intangibles amortization, see Note 7 Acquired Intangibles and Goodwill to the condensed consolidated financial statements contained elsewhere in this Report.

Restructuring Costs. Restructuring costs of $11.3 million in the three months ended March 26, 2022 are primarily related to activities intended to gain synergies from our recent DSPG acquisition as well as an acceleration of vesting on certain equity awards. Restructuring activities commenced in fiscal 2022 and are expected to be complete by the end of the fourth quarter of fiscal 2022. For further discussion of restructuring costs, see Note 16 Restructuring Activities to the condensed consolidated financial statements contained elsewhere in this Report.

Restructuring costs of $17.8 million in the nine months ended March 26, 2022 reflect severance costs for restructuring of our operations to reduce ongoing operating costs and for activities intended to gain synergies from our recent DSPG acquisition as well as an acceleration of vesting on certain equity awards. Restructuring activities commenced in fiscal 2022 and are expected to be complete by the end of the fourth quarter of fiscal 2022.

Interest and Other Expense, Net. Interest and other expense, net, primarily includes interest on our debt, amortization of debt discount and issuance costs, partially offset by interest income earned on our cash, cash equivalents and short-term investments and a gain recognized on settlement of a supplier agreement. Interest and other expense, net decreased by $0.3 million to $6.7 million for the three months ended March 26, 2022, as compared to $7.0 million for the three months ended March 27, 2021.

Interest and other expense, net, increased $0.6 million to $18.3 million for the nine months ended March 26, 2022, as compared to $17.7 million for the nine months ended March 27, 2021. The increase in interest and other expense, net, is primarily due to interest and amortization of debt issuance costs on the $400.0 million principal amount of Senior Notes issued in March 2021 and the $600 million incremental term loan facility executed in December 2021, partially offset by lower interest and amortization of debt issuance costs and discount on the convertible notes which were partially redeemed in the fourth quarter of fiscal 2021 and fully redeemed in the first quarter of fiscal 2022.

Gain from sale and leaseback transaction. Gain from sale and leaseback transaction represents the gain from the sale of our headquarters buildings and properties located at 1109-1251 McKay Drive and 1140-1150 Ringwood Court, San Jose, California. The sale and leaseback transaction was completed in the third quarter of fiscal 2022. For further discussion of the sale and leaseback transaction, see Note 8 Leases to the condensed consolidated financial statements contained elsewhere in this Report.

Loss on redemption of convertible notes. Loss on redemption of convertible notes, which began in the fourth quarter of fiscal 2021 and was completed in the first quarter of fiscal 2022, represents the difference between fair value and the carrying value as of the redemption date.

Provision for Income Taxes. We account for income taxes under the asset and liability method. The provision for income taxes recorded in interim periods is based on our estimate of the annual effective tax rate applied to year-to-date income before provision for income taxes, adjusted for discrete items required to be recognized in the period in which they are incurred. In each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, we make a cumulative adjustment in that quarter. Our quarterly tax provision and our quarterly estimate of the annual effective tax rate can be subject to volatility due to several factors, including our ability to accurately forecast annual income before provision for income taxes in each of the tax jurisdictions in which we operate.

The provision for income taxes of $32.3 million and $16.4 million for the nine months ended March 26, 2022 and March 27, 2021, respectively, represented estimated federal, foreign, and state income taxes. The effective tax rate for the nine months ended March 26, 2022 diverged from the combined U.S. federal and state statutory tax rate primarily because of the benefit of income taxed at lower rates, research credits and foreign tax credits, partially offset by foreign withholding taxes, non-deductible officer compensation and GILTI. The effective tax rate for the nine months ended March 27, 2021, diverged from the combined U.S. federal and state statutory tax rate, primarily because of the benefit of income taxed at lower rates, research credits and foreign tax credits, partially offset by foreign withholding taxes and GILTI.

Liquidity and Capital Resources

Our cash and cash equivalents were $690.3 million as of March 26, 2022, compared with $836.3 million as of June 26, 2021, representing a decrease of $146.0 million. The decrease primarily reflected $505.6 million used for the payment for the redemption of convertible notes, net cash paid to acquire DSPG of $504.8 million, $66.1 million used for payroll taxes on the delivery of the underlying shares for Restricted Stock Units, or RSUs, Market Stock Units, or MSUs and Performance Stock Units, or PSUs, $26.9 million for the purchase of property and equipment, offset by proceeds from the term loan facility of $588.8, net of debt issuance costs paid of $11.2 million, proceeds from the sale of property and equipment of $55.9 million and $308.4 million of net cash provided by operating activities.

We consider almost all of the earnings of our foreign subsidiaries as not indefinitely invested overseas and have made appropriate provisions for income or withholding taxes that may result from a future repatriation of those earnings. As of March 26, 2022, $563.2 million of cash, cash equivalents and short-term investments was held by our foreign subsidiaries. If these funds are needed for our operations in the United States, we would be able to repatriate these funds without impacting our tax provision.

Cash Flows from Operating Activities. Operating activities during the nine months ended March 26, 2022 generated $308.4 million compared with $214.3 million net cash generated during the nine months ended March 27, 2021. For the nine months ended March 26, 2022, the primary operating activities were adjustments for non-cash charges of $164.5 million and a net change in operating assets and liabilities of $30.7 million. The net change in operating assets and liabilities was primarily attributable to a $57.3

million increase in accounts receivable, a $41.3 million increase in inventories, $21.1 million increase in accounts payable, and an increase of $31.1 million in income taxes payable and other accrued liabilities.

For the nine months ended March 27, 2021, the primary operating activities were adjustments for non-cash charges of $126.3 million and a net change in operating assets and liabilities of $27.4 million. The net change in operating assets and liabilities was primarily attributable to a $65.8 million decrease in inventories and a $37.9 million increase in accounts payable, partially offset by a $31.3 million increase in accounts receivable, net, a $19.3 million decrease in other accrued liabilities, a $11.8 million decrease in income taxes payable, and a $7.9 million increase in prepaid expenses and other current assets.

During the nine months ended March 26, 2022, our days sales outstanding was 57 days compared to 65 days at the same period a year ago. Our annual inventory turns decreased from eight to five over the same time period.

Cash Flows from Investing Activities. Cash used in investing activities during the nine months ended March 26, 2022 consisted of $469.4 million compared with $517.0 million net cash used during the nine months ended March 27, 2021. Net cash used in investing activities for the nine months ended March 26, 2022 consisted of $55.9 million proceeds from the sale of property, partially offset by $504.8 million for the DSPG acquisition and $26.9 million for purchases of property and equipment. Cash used in investing activities during the nine months ended March 27, 2021 consisted of $626.5 million used for the acquisition of businesses and $15.5 million for purchases of property and equipment, partially offset by $95.8 million in proceeds from maturities of investments and $34.2 million of proceeds from sale of audio technology assets.

Cash Flows from Financing Activities. Cash provided by financing activities for the nine months ended March 26, 2022 was $16.9 million compared with $294.0 million used in financing activities for the nine months ended March 27, 2021. Net cash provided by financing activities for the nine months ended March 26, 2022 consisted of proceeds received from the term loan facility of $588.8 million (net of debt issuance costs paid of $11.2 million) and $15.1 million proceeds from issuance of shares, offset by a $505.6 million payment for redemption of convertible notes, $66.1 million used for payroll taxes on the delivery of the underlying shares for RSUs, MSUs and PSUs, and $16.6 million used for refundable deposit paid to vendor. Net cash used in financing activities for the nine months ended March 27, 2021 consisted of $400.0 million of proceeds from issuance of debt and $26.9 million of proceeds from issuance of shares, partially offset by primarily a $100.0 million payment on line of credit borrowings and $27.0 million used for payroll taxes on RSUs, MSUs and PSUs.

Common Stock Repurchase Program. As of March 26, 2022, our board has cumulatively authorized $1.8 billion for our common stock repurchase program, which will expire in July 2025. The program authorizes us to purchase our common stock in the open market or in privately negotiated transactions, depending upon market conditions and other factors. The number of shares purchased and the timing of purchases are based on the level of our cash balances, general business and market conditions, and other factors. Common stock purchased under this program is held as treasury stock. From April 2005 through March 26, 2022, we purchased 31,749,195 shares of our common stock in the open market for an aggregate cost of $1.2 billion. During the nine months ended March 26, 2022, we did not repurchase any shares of our common stock. As of March 26, 2022, the remaining available authorization under our common stock repurchase program was $577.4 million.

Senior Debt

On March 11, 2021, we completed an offering of $400.0 million aggregate principal amount of 4.0% senior notes due 2029, or the Senior Notes, in a private offering. The Senior Notes were issued pursuant to an Indenture, dated as of March 11, 2021, or the Indenture, by and among our company, the guarantors named therein and Wells Fargo Bank, National Association, as trustee.

The Indenture provides that the Senior Notes will bear interest at a rate of 4.000% per annum, payable in cash semi-annually in arrears on December 15 and June 15 of each year, commencing on June 15, 2021. The Senior Notes will mature on June 15, 2029 and are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by each of our current and future domestic restricted subsidiaries that guarantee our obligations under our senior secured credit facilities.

We may redeem some or all of the Senior Notes on or after June 15, 2024 at the redemption prices specified below, plus accrued and unpaid interest, if any, to, but excluding, the redemption date:


Year	Price
2024		102	%
2025		101	%
2026 and thereafter		100	%

In addition, at any time prior to June 15, 2024, we may redeem up to 40% of the aggregate principal amount of the Senior Notes at a redemption price equal to 104% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date with the net cash proceeds from one or more equity offerings by us.

Bank Credit Facility

On March 11, 2021, we entered into a Second Amended and Restated Credit Agreement, or the Credit Agreement, with the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent to, among other changes, extend the maturity date of our senior secured revolving credit facility, to five years from the closing date of the amendment, increase the facility size from $200.0 million to $250.0 million, and replace the requirement to maintain a total debt to Consolidated EBITDA ratio (as defined in the Credit Agreement) of not more than 4.75 to 1.00 with a requirement to maintain a net total debt to Consolidated EBITDA ratio of not more than 3.75 to 1.00 provided that for the four fiscal quarters ending after the date of a material acquisition, such maximum leverage ratio shall be adjusted to 4.25 to 1.00, and thereafter 3.75 to 1.00, provided further, that such deemed increase pursuant to the foregoing shall not apply to more than two material acquisitions consummated during the term of the Credit Agreement.

based on a sliding scale that ranges from 0.25 to 100 basis points for Base Rate loans and 100 basis points to 175 basis points for LIBOR loans. We are required to pay a commitment fee on any unused commitments under the Credit Agreement which is determined on a leverage-based sliding scale ranging from 0.175% to 0.25% per annum. Interest and fees are payable on a quarterly basis. The LIBOR index is expected to be discontinued at the end of 2021. Under our credit facility, when the LIBOR index is discontinued, we will switch to a comparable or successor rate as selected by us and the administrative agent, which may include the Secured Overnight Financing Rate, or SOFR.

Under the Credit Agreement, there are various restrictive covenants, including two financial covenants that limit the consolidated total leverage ratio, or leverage ratio, the consolidated interest coverage ratio, or interest coverage ratio, a restriction that permits accounts receivable financings provided that the aggregate unpaid amount of permitted accounts receivable financings are no more than the greater of $100 million and 50% of the amount of all accounts receivable of the company and specified subsidiaries, and other specific items. The leverage ratio is the ratio of debt as of the measurement date to Consolidated EBITDA, for the four consecutive quarters ending with the quarter of measurement. The current leverage ratio shall not exceed 3.75 to 1.00 provided that for the four fiscal quarters ending after the date of a material acquisition, such maximum leverage ratio shall be adjusted to 4.25 to 1.00, and thereafter 3.75 to 1.0. The interest coverage ratio is Consolidated EBITDA to interest expense for the four consecutive quarters ending with the quarter of measurement. The interest coverage ratio must not be less than 3.50 to 1.0 during the term of the Credit Agreement. As of March 26, 2022, we remain in compliance with the restrictive covenants.

Term Loan Facility

In December 2021, we entered into that certain First Amendment and Lender Joinder Agreement to the Credit Agreement, to, among other things, establish a new $600.0 million incremental term loan facility, or the Term Loan Facility. The Term Loan Facility was advanced by certain existing and new lenders under the Credit Agreement to finance our DSPG acquisition. The Term Loan Facility matures on December 2, 2028. Principal on the Term Loan Facility is payable in equal quarterly installments on the last day of each March, June, September and December of each year, beginning December 31, 2021, at a rate of 1.00% per annum.

$100 Million Shelf Registration. We have registered an aggregate of $100.0 million of common stock and preferred stock for issuance in connection with acquisitions, which shares will generally be freely tradeable after their issuance under the Securities Act unless held by an affiliate of us, in which case such shares will be subject to the volume and manner of sale restrictions of Rule 144 of the Securities Act.

Working Capital Needs. We believe our existing cash and cash equivalents, anticipated cash flows from operating activities, anticipated cash flows from financing activities, and available credit under our revolving credit facility, will be sufficient to meet our working capital and other cash requirements, including acquisitions, and our debt service obligations, for at least the next 12 months. Our future capital requirements will depend on many factors, including our revenue, the effectiveness of vaccines on variants of COVID-19, including the deployment of those vaccines to help reduce the length, duration and severity of the COVID-19 pandemic, the timing and extent of spending to support product development efforts, costs associated with restructuring activities net of projected savings from those activities, costs related to protecting our intellectual property, the expansion of sales and marketing activities, timing of introduction of new products and enhancements to existing products, costs to ensure access to adequate manufacturing, costs of maintaining sufficient space for our workforce, the continuing market acceptance of our product solutions, our common stock repurchase program, and the amount and timing of our investments in, or acquisitions of, other technologies or companies. Further equity or debt financing may not be available to us on acceptable terms or at all. If sufficient funds are not available or are not available on acceptable terms, our ability to fund our future long-term working capital needs, take advantage of business opportunities or to respond to competitive pressures could be limited or severely constrained.

Based on our ability to access our cash and cash equivalents, our expected operating cash flows, and our other sources of cash, we do not currently anticipate the need to remit undistributed earnings of our foreign subsidiaries to meet our working capital and other cash requirements, but if we did remit such earnings, we may be required to pay certain state and foreign taxes to repatriate these funds, which could adversely impact our financial position.

Contractual Obligations and Commercial Commitments

Our material contractual obligations and commercial commitments as of March 26, 2022 were as follows (in millions):


	Payments due by period
Contractual Obligations	Total		Less than 1 year		1-3 Years		3-5 Years		Thereafter
Long-term debt (1)	$	1,118.5	$	9.5	$	44.0	$	44.0	$	1,021.0
Leases		76.5		1.5		19.4		18.5		37.1
Purchase obligations and other commitments (2)		280.2		46.9		176.2		57		-
Transition tax payable (3)		7.4		0.3		4.1		3.0
Total	$	1,482.6	$	58.2	$	243.7	$	122.6	$	1,058.1

(1)

Represents the principal and interest payable through the maturity date of the underlying contractual obligation.

(2)

Purchase obligations and other commitments include payments due for inventory purchase obligations with contract manufacturers, long-term software tool licenses, and other licenses.

(3)

Represents the remaining balance of the one-time transition tax liability associated with our deemed repatriation of accumulated foreign earnings as a result of the enactment of the Tax Cuts and Jobs Act into law on December 22, 2017.

The amounts in the table above exclude gross unrecognized tax benefits related to uncertain tax positions of $37.0 million. As of March 26, 2022, we were unable to make a reasonably reliable estimate of when cash settlement with a taxing authority may occur in connection with our gross unrecognized tax benefit.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As of March 26, 2022, our market risk related to interest rates on our cash and cash equivalents, and foreign currency exchange risks has not changed materially from the risks disclosed in Item 7A of our Annual Report on Form 10-K for the fiscal year ended June 26, 2021.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, are recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and to reasonably ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Due to the COVID-19 pandemic, a portion of our employees are working from home while under governmental restrictions. Established business continuity plans were initiated in order to mitigate the impact to our control environment, operating procedures, data and internal controls. The design of our processes and controls allow for remote execution with accessibility to secure data.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Report.

Changes in Internal Control over Financial Reporting

We assessed, with the participation of our CEO and CFO, any change in our internal control over financial reporting as of the end of the fiscal quarter covered by this Report.

On December 2, 2021, we completed the DSPG acquisition. Under guidelines established by the SEC, companies are permitted to exclude acquisitions from their assessment of internal control over financial reporting during the first year of an acquisition while integrating the acquired company. In conducting our evaluation of the effectiveness of our internal control over financial reporting, we excluded DSPG from our evaluation for the period ended March 26, 2022. We are in the process of integrating DSPG into our system of internal control over financial reporting.

Except as noted above, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period ended March 26, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are party to various litigation matters and claims arising from time to time in the ordinary course of business. While the results of such matters cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows.

ITEM 1A. RISK FACTORS

We refer you to the Company’s risk factors set forth in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended June 26, 2021 for material risks that may affect our business. There have been no material changes from the risk factors previously disclosed.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

Our Board of Directors has cumulatively authorized $1.8 billion for our common stock repurchase program, which expires at the end of July 2025. As of March 26, 2022, the remaining amount authorized for the repurchase of our common stock was $577.4 million. During the three-month period ended March 26, 2022, we did not repurchase any shares under our common stock repurchase program.

ITEM 6. EXHIBITS


31.1		Certification of Chief Executive Officer

31.2		Certification of Chief Financial Officer

32.1*		Section 1350 Certification of Chief Executive Officer

32.2*		Section 1350 Certification of Chief Financial Officer

101.INS Inline		XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH Inline		XBRL Taxonomy Extension Schema Document

101.CAL Inline		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF Inline		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB Inline		XBRL Taxonomy Extension Label Linkbase Document

101.PRE Inline		XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

* This information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	SYNAPTICS INCORPORATED

Date: May 5, 2022	By:	/s/ Michael E. Hurlston
	Name:	Michael E. Hurlston
	Title:	President and Chief Executive Officer

Date: May 5, 2022	By:	/s/ Dean Butler
	Name:	Dean Butler
	Title:	Senior Vice President and Chief Financial Officer
Date: May 5, 2022	By:	/s/ Kermit Nolan
	Name:	Kermit Nolan
	Title:	Corporate Vice President and Chief Accounting Officer